Many care providers have a pharmacy that prepares medical doses for administration to patients that are treated by the care provider. In this regard, the pharmacies may employ a formulary to prepare medications in order to fulfill medical dose orders that are ordered by care provider personnel (e.g., physicians) for administration to patients. Some medical doses to be prepared may include compounded sterile products (CSPs) that may be prepared in a specially constructed and controlled environment (e.g., an “IV Room”) in the pharmacy. The process of preparing medical doses may be carried out in accordance with local care provider policy, governmental regulations, industry organizations (e.g., Chapter <797> of the United States Pharmacopoeia), or other applicable policies. For example, the preparation of medications may generally occur in a laminar airflow hood, isolator, or biological safety cabinet, by an operator (typically a pharmacy technician) who is tasked with preparing the medical doses. Once the medical doses are prepared, the medical doses may be required to be verified by a pharmacist prior to being dispensed from the pharmacy for administration to a patient.
In traditional pharmacy management techniques, medical dose orders may be provided to a printer that prints labels indicative of the medical dose order that are to be applied to finished doses once the doses are prepared. A pharmacy technician may be required to retrieve labels from a label printer and use those labels as work order travelers in the process of preparing each dose. Once the dose is prepared, the technician may apply a label to the dose. The completed, labeled dose may be set aside for a pharmacist to check along with, for example, source ingredients, medication receptacles used in the course of preparing the dose, and/or other material. In this regard, in order to check a dose, the pharmacist may be required to enter the clean room in which the doses are prepared and physically observe the materials associated with the dose order. As such, the checking of prepared doses may require the pharmacist to dress in protective clothing or equipment, which takes time and resources.
Furthermore, the only prompt a pharmacy may receive to prepare a medical dose order is the printing of the label. In this regard, if a label becomes lost or damaged, a dose may not be prepared. Additionally, prioritizing work also becomes difficult because the label stack at the label printer may be the only evidence of what doses have been ordered, prepared, and/or dispensed. As such, relying on physical labels alone to track doses may result in unprepared, lost, or duplicate doses. In some cases, pharmacies may produce duplicate labels as a matter of course such that the pharmacy must review each label against the other, already received labels, to determine if a label represents a new dose order that needs to be prepared. This practice may lead to increased administrative overhead in the pharmacy that add operational costs and reduce pharmacy efficiency.
Furthermore, while instructions for preparation of a drug may be recorded in official FDA-approved literature for the drug, pharmacy technicians may not reliably consult the literature when preparing doses. Rather, pharmacy technicians may memorize the steps needed for the most common drugs, and then generalize those steps to other drugs to be prepared without verifying the protocols associated with a particular drug. In this regard, if the dose order includes special instructions that a pharmacy technician does not recognize, references regarding the proper techniques may not be present or may not be consulted. Accordingly, dose orders including special instructions often must be prepared by more experienced technicians or at the direction of more experienced technicians. In either regard, the protocol used to prepare the dose may not conform to the FDA-approved literature for the drug being prepared.
Further still, in traditional pharmacy management techniques, the pharmacy technician may be responsible for creating records that are maintained in relation to doses that have been prepared and products from the formulary that were employed to make the dose. For example, a pharmacy technician may be tasked with transcribing information such as lot numbers, expiration dates, serial numbers, or the like. The manual creation of records requires labor intensive practices that may result in pharmacy inefficiencies, introduces the potential for errors in the records, and may result in virtually unsearchable paper records.
In this regard, the present disclosure relates to embodiments of a medical dose preparation management system. The medical dose preparation management system may be capable of receiving dose orders, creating digital dose orders from the received dose orders, and managing the digital dose orders. For example, the medical dose preparation management system may be operable to create and store information related to the preparation of medical doses. Such information may be used to verify a medical dose order by a pharmacist, track a medical dose order in a pharmacy or care provider, be retained in connection with the digital dose order record for auditing, compliance, or quality assurance purposes, or otherwise be utilized in the management of the dose order before or after administration to a patient. In other words, the medical dose preparation management system may provide, in an automatic manner, an improved system that allows tracking a medical dose order in a pharmacy or care provider. The medical dose preparation management system may provide, in an automatic manner that the medical dose be retained in connection with the digital dose order record for auditing, compliance, or quality assurance purposes, or otherwise be utilized in the management of the dose order before or after administration to a patient. Hence, the medical dose preparation management system provides an improved man machine interaction, among others meeting the high level of compliance requirements in drug manufacturing and distribution with little or without any interference of a human personnel necessary. One example of information that may be created and stored in connection with a medical dose order is one or more medical dose preparation images. For example, a work station at which a dose order is prepared may include an imaging device (e.g., a digital camera) capable of capturing images related to the preparation of the medical dose. In an embodiment, the medical dose preparation images may include medication receptacles used in the preparation of the dose including, for example, a source receptacle, a transference receptacle, and/or an administration receptacle. Accordingly, the medical dose preparation images may be used to document or evidence the preparation of a medical dose order. Thus, the system provides an improved man machine interaction since less or even no interaction by a human person is necessary and still allows for accurate and trustworthy documentation.
Given the potential for capturing and storing a large number of medical dose preparation images, it may be advantageous to reduce the size in memory of medical dose preparation images. However, as such images may be used in a variety of contexts (e.g., including during verification of dose orders by a pharmacist), image quality is generally of great concern such that resolution is preferably not reduced when storing medical dose preparation images. In this regard, reduction in the physical size of an image (i.e., cropping the image to remove uninformative or useless portions of the image) may be used to effectively reduce the size of a medical dose preparation image in memory without reducing the resolution of the image.
However, manually cropping each medical dose preparation image may be burdensome and increase the cost and time required to prepare doses. In this regard, an apparatus described herein may employ an auto cropping operation to automatically reduce the size in memory of medical dose preparation images. For example, a region of interest in an image may be determined. The region of interest in an image may be captured as a medical dose preparation image that eliminates at least a portion of image data not within the region of interest.
Thus, the amount of image data stored in memory may be reduced without a reduction in resolution of the corresponding image and/or the resolution of a captured image may be increased while maintaining or reducing the amount of corresponding image data stored in memory. That is, for a given image resolution, the amount of corresponding image data may be reduced by reducing the size of the image. Thus, with little hardware resources, e.g., little memory capacity, a large amount of data can be stored. Moreover, with little hardware resources, e.g., little processing power, image data can be processed.
Additionally or alternatively, for a given amount of image data, a higher resolution image may be stored if the corresponding image data is only that of a cropped portion of the image. Accordingly, if the amount of image data is reduced, the computational overhead required to process, store, or otherwise take action with respect to the image may be reduced such that work flows at the work station may occur more quickly. Additionally or alternatively, if the resolution of an image is increased, a review of the image may be improved by allowing for capture of finer details (e.g., to allow for magnification of the image during a review by a pharmacist or the like).
In this regard, a first aspect described herein includes an apparatus for processing medical dose preparation image data in a system for medical dose preparation management. The system includes an imaging device (e.g., a digital camera) having an imaging field encompassing a medical dose preparation staging region. The imaging device is operable to output digital image data (e.g., corresponding to still digital images, a digital video data stream, and/or other forms of digital image data) of the imaging field including the medical dose preparation staging region. The system also includes a processor in operative communication with the imaging device to receive the digital image data of the imaging field. The system allows for automation of documenting medical dose order preparation and/or delivery. In particular the system may allow for such automation at a very high speed and/or increased image resolution which would otherwise not be possible by a human person. In other words, the system advantageously combines digital image processing with medical dose order preparation and/or drug delivery that would otherwise not have been done, since, according to this application, data processing may be carried at a high speed and/or with increased image resolution.
The system of the first aspect may include a display that is in operative communication with the processor to receive the digital image data of the imaging field and display a corresponding image that is perceivable by a user. The processor is operable to process the digital image data to identify at least one region of interest within the imaging field corresponding to at least one medication receptacle disposed in the medical dose preparation staging region. As such, in the event a display is utilized as described above, the region of interest may be visually differentiated on the display by the processor in a manner perceivable by the user. Hence, by the system, without the need of physically controlling the imaging device or accessing one or more medication receptacles at the medical dose preparation staging region, by a human person, it is possible to allow for the high level of documentation desired in medical dose preparation and/or delivering. In other words, the system allows relieving the human person from and/or assisting the user in the task of manual steps to obtain detailed documentation (e.g., detailed image data). Even more, since the documentation is machine aided or even completely carried out by the machine, namely the system described in this application, the documentation is more reliably or trustworthy as compared to the documentation by a human person. It may even only be possible to assure such documentation since the system strictly follows machine rules without deviation such as are possible for a human person.
The system of the first aspect may also include a user control device that is in operative communication with the processor to initiate the capture of a medical dose preparation image data from the digital image data. Other embodiments may include other mechanisms for initiating the capture of a medical dose preparation image. In any regard, the medical dose preparation image data may include image data corresponding to at least a portion of the region of interest and may exclude at least a portion of the imaging field (e.g., corresponding to a portion of the image data outside the region of interest). The system may also include a memory in operative communication with the processor to receive and store the medical dose preparation image data. The user control device provides for improved man machine interaction due to, e.g., in connection with the processor automatically processing the image.
A number of feature refinements and additional features are applicable to the first aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the following features that will be discussed may be, but are not required to be, used with any other feature or combination of features of the first aspect. In an embodiment, the processor may be operable to analyze the digital image data to identify the region of interest. For example, the processor may be operable to analyze a predetermined subset of the digital image data (e.g., a subset of the pixels of the digital image data) to identify the region of interest. The subset may correspond to a predetermined portion of the digital image data such that the analysis of the image data may be executed on a portion, but not the entirety of the digital image data.
In an application, the analysis may include comparing the digital image data to a background image of the medical dose preparation staging region. In this regard, the background image may not include any medication receptacle in the medical dose preparation staging region. That is, the background image may represent the appearance of the medical dose preparation staging region in the absence of any object (e.g., a medication receptacle or the like). Accordingly, the predetermined subset of the digital image data may be compared to a corresponding subset of the background image. For example, corresponding ones of the subset of pixels in the digital image data and the background image may be compared.
In an application, the plurality of pixels may extend across substantially the entire digital image data in at least a first direction (e.g., a width of the image data). Additionally, the plurality of pixels may extend across substantially all of the digital image data in a second direction perpendicular to the first direction (e.g., a height of the image data). As such, the plurality of pixels corresponding to the predetermined subset of the image data may form a grid over the digital image data. The grid may comprise grid lines that are spaced in relation to a known size of medication receptacles. For instance, the grid lines may be spaced such that at least two grid lines cross the medical receptacle in at least two dimensions (e.g., corresponding to both a width and a length of the receptacle) even for the smallest known medication receptacle to be imaged.
In an embodiment, the region of interest may be defined by a bounding area defined by a plurality of edges. Each of the plurality of edges may be disposed at an identified location of the predetermined subset of the digital image data (e.g., along at least a portion of a grid line) at least partially based on a threshold difference between the digital image data and the background image at the identified location. In one example, the processor may be operable to calculate intensity data for each pixel of the predetermined subset of the digital image data and for each pixel of the corresponding predetermined subset of the background image. The intensity data may be filtered (e.g., high pass and/or low pass filtering). The threshold difference may correspond to a predetermined difference in intensity data between the predetermined subset of the digital image data and the background image.
In various embodiments, the digital image data may include discrepancies relative to the background image that, rather than being attributable to the presence of a medication receptacle, are solely attributable to slight variations in positions of the background image relative to the background of the digital image data, lighting variations, or other minor discrepancies. In this regard, each pixel of the predetermined subset may be compared to a plurality of adjacent corresponding pixels from the background image. In this regard, insignificant variations related to the discrepancies disclosed above may be disregarded in the analysis.
In an application, the identified location resulting from the comparison of intensity data between the digital image data and the background image may correspond to one of a minimum and/or maximum threshold difference along the grid lines in a first direction and/or in a second direction. That is, two threshold differences may be identified in either or both of the first and second direction corresponding to the extents of the medication receptacle in the width and/or height dimension. In still another application, the identified location may be selected to correspond to the next most remote grid line of the grid exterior to the threshold difference in the first direction and in the second direction along the grid line. As such, if a portion of the medication receptacle extends beyond a grid line along which a threshold difference is identified, the full portion of the receptacle may still be contained in the region of interest if the identified location is selected as the next remote grid line. Summarizing the above, the system provides an improved man machine interaction, e.g., by relieving the user from and/or assisting the user in the manual and/or mental task to control the imaging device or manipulate one or more medication receptacles.
A second aspect described herein includes a method for processing and capturing medical dose preparation image data. The method includes encompassing a medical dose preparation staging region in an imaging field of an imaging device. The method further includes obtaining digital image data of the imaging field. The method also includes identifying, at a processor in operative communication with the imaging device, a region within the imaging field corresponding to at least one medication receptacle disposed in the medical dose preparation staging region. The method may also include displaying the digital image data on a display. The region of interest may be visibly distinguished by the processor on the display in a manner that is perceivable by a user.
The method of the second aspect may also include receiving an input from a user control device to initiate capture of medical dose preparation image data from the digital image data. The medical dose preparation image data includes image data corresponding to at least a portion of the region. The method further includes storing the medical dose preparation image data in a memory. In various method embodiments, the method may employ a system comprising any of the system features described herein.
According to yet another aspect, a computer program product is provided that can be stored on a computer readable medium and/or can be implemented as computer processable data stream, wherein the computer program product comprises computer processable instructions, which instructions when read in the memory of a computer and executed by the computer cause the computer to carry out the method(s) as described in general above, and in more specific examples below.
A number of feature refinements and additional features are applicable to the second aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the following features that will be discussed may be, but are not required to be, used with any other feature or combination of features of the second aspect.
For example, the speed at which the identifying operation occurs may be important to the method of the second aspect. As may be appreciated, the volume of dose orders prepared in a pharmacy or the like may be relatively large. As such, efficient preparation of the medical dose order may be of great importance. In this regard, it may be desirable to have any auto cropping operation occur relatively quickly so as to prevent preparation delays when preparing the medical dose order.
Accordingly, in an embodiment, the digital image data may comprise a video stream data. In this embodiment, the identifying may occur more rapidly than a refresh rate of the video data stream. As such, each successive frame of the video data stream may undergo the auto cropping operation without slowing the speed at which the video data stream is captured or displayed.
Numerous additional features and advantages of the present invention will become apparent to those skilled in the art upon consideration of the embodiment descriptions provided hereinbelow.
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that it is not intended to limit the invention to the particular form disclosed, but rather, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the claims.
The medical dose orders received at the dose order input 20 may be specific to patients or may be orders that are not associated with a patient at the time of ordering. In this regard, the medical dose order may correspond to a contained medication unit that may comprise one of the following: a patient specific unit comprising a medication unit designated for administration to a specific patient; a non-patient specific unit comprising a medication unit to be subsequently designated for administration to a specific patient; or, a medication component source unit to be used in the preparation of a patient specific unit or a non-patient specific unit (e.g., that will be designated for administration to a specific patient after preparation).
Examples of contained medication units that may correspond to medication dose orders include: compounded sterile products; injectable medications; chemotherapy preparations; or nutritional supplements requiring administration by a patient care provider (e.g., sterile injectable nutritional supplements).
In the latter regard, nutritional supplements may include total parenteral nutrition (TPN) or components of TPN. Furthermore, nutritional supplements may include partial nutritional supplements. The nutritional supplements may include a pre-mix bag, base and additive components separately or in combination, or other forms of nutritional supplements or components thereof. The nutritional supplements may be for administration via intravenous injections, in an edible form, or for use with a feeding tube or the like.
In any regard, the medical dose may include one or more portions of information that may be used to assist in preparation of the mediation dose, may be associated with the administration of the dose order to a patient, or may otherwise relate to the dose order. For example, the dose order may include information corresponding to: a medication identity; a medication amount; a medication concentration;
In any regard, the medical dose orders may be communicated to a medical dose preparation management system 30. The medical dose preparation management system 30 may be operable to acquire 50 dose order data from the dose order information received from the order processor 20. The medical dose preparation management system 30 may also preprocess 52 dose order data. The preprocessing 52 may include, for example, generating a digital dose order record that is maintained by the medical dose preparation management system 30. The digital dose order record may be automatically populated with data that may be obtained from the order such as, for example, any of the information described above in connection with the medical dose order. In this regard, information may be parsed, scraped, or otherwise obtained from the medication dose order received at the order input 20. Specifically, in an embodiment, the medical dose preparation management system 30 may be operable to scrape data addressed to a human readable output (e.g., a printer) from the order input 20 to populate the medical dose order record with data corresponding to the medical dose order.
In an embodiment, the medical dose preparation management system 30 may be in operative communication with a medication dose order database 32. In this regard, the medication dose order database 32 may be located at the care provider facility (i.e., be onsite relative to the care provider hospital 12). The medical dose preparation management system 30 may additionally or alternatively be operable to communicate with a remote medication dose order database 34. In this regard, the medical dose preparation management system 30 may communicate with the remote medication dose order database 34 via a network or the like. In either regard, the medication dose order database 32 or 34 may be operable to store medication dose order records in the medication dose order database 32 and/or 34. In addition, the medication dose order database 32 or 34 may store dose order metadata in corresponding relation to respective ones of the stored medication dose orders. The medication dose order database 32 or 34 may store active dose orders (e.g., corresponding to dose orders that have been generated but not yet administered to the patient) or archived dose orders (e.g., corresponding to dose orders that have been administered to a patient). Redundant data may be stored at the on-site medical dose order database 32 and the off-site medical dose order database 34. For example, the off-site medical dose order database 34 may be a backup version of the on-site medical dose order database 32.
In any regard, medical dose order metadata may be stored in corresponding relation to a medication dose order. The medical dose order metadata may include, for example, the following types of data: medication source data indicative of at least one of: a manufacturer of a component of the contained medication unit corresponding to the medication dose order, a lot number of a component of the contained medication unit corresponding to the medication dose order, an expiration date of a component of the contained medication unit corresponding to the medication dose order, a serial number of a component of the contained medication unit corresponding to the medication dose order, or a drug code indicative of the identity of a component of the contained medication unit corresponding to the medication dose order; chain of custody data indicative of at least one of: a listing of entities in possession of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of users that have taken an action with respect to the contained medication unit corresponding to the medication dose order, wherein the listing of users is correlated to specific actions taken by each user, or tracking information corresponding to physical movement of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order; fulfillment data indicative of at least one of: image data corresponding with a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, scanned data obtained from a component of the contained medication unit corresponding to the medication dose order, analytic data regarding a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, pharmacist review data corresponding with at least one pharmacist review of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, compliance data corresponding with best practices associated with a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, sterility assessment data corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of actions corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, time stamp data corresponding to actions corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of life cycle events taken with respect a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, or weight data corresponding to a measured and/or anticipated weight of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order; or environmental data indicative of at least one of: a temperature to which a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order has been exposed, a temperature to which and corresponding time period for which a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order has been exposed, whether a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order is refrigerated, whether a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order is frozen, a temperature profile experienced by a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, or accelerometer data corresponding to forces experienced by a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order.
As may be appreciated from the foregoing description of the medical dose order metadata, a medical dose order may inherit metadata from components used in the preparation of the medical dose order. In a simple example, a medical dose order may include a first component (e.g., a drug) to be mixed with a second component (e.g., a diluent). The first component may have one or more portions of metadata as described above that are associated with the first component. Additionally, the second component may have one or more portions of metadata as described above that are associated with the second component. Thus, a medical dose order that is prepared using the first component and the second component may inherit the metadata from each of the first component and second component. In this regard, a plurality of generations of metadata may be compiled and attributed for a given medical dose order. In an embodiment, metadata for any and all components used to prepare the dose order may be compiled and attributed for a given medical dose order. As such, metadata information for the medical dose order may include metadata originating with source components provided by a manufacturer of the components of a dose order.
The medical dose preparation management system 30 may also be operative to organize 54 dose orders. The organization 54 may include prioritization, scheduling, or other tasks associated with the organization or management of dose orders. The medical dose preparation management system 30 may also be operative to route 56 dose orders to an appropriate work station 40 for use in fulfillment of the dose order. In this regard, a plurality of work stations 40 may be provided in communication with the medical dose preparation management system 30. Different ones of the plurality of work stations 40 may each be suited for different operations related to medical dose order management. As such, depending on the nature of a medical dose, a particular type of work station 40 may be used to prepare the dose. The work station 40 may be on-site relative to the care provider hospital 12 as depicted in
In any regard, the medical dose preparation management system 30 may be in operative communication with one or more work stations 40. The routing 56 of dose orders may be at least partially based on one or more factors related to the dose order or the preparation of the dose order. For example, as stated above, the nature of the contained medication unit corresponding to the dose order (e.g., whether a dose order is a chemotherapy dose order, a parenteral dose order, or other specialized dose order) may factor into a determination regarding the routing 56 of the dose order. Additionally or alternatively, the capabilities of the various work stations 40 in relation to the manner in which the dose order is to be prepared may be considered. For example, some orders may require different levels of containment, hooding, or other precautions that may or may not be provided at each work station 40. In an embodiment, other parameters such as technician schedules, work station schedules, work station location, medication dose order scheduling information, or other information may be used alone or in combination to route 56 dose orders to a particular work station 40.
At the work station 40, a work flow corresponding to the preparation of the medical dose order may be displayed 58. In this regard, a work flow that is specific to the medical dose order currently being prepared at the work station 40 may be presented to a technician at the work station 40 to assist or provide guidance to the technician preparing the dose order. Accordingly, the technician may follow a sequence of steps to prepare the medical dose based on the work flow displayed 58 that relates to the dose order.
During and/or after the preparation of the dose order, the work station 40 may be used to assist in obtaining 60 dose order metadata related to the medical dose order. For example, the work station 40 may allow for recording of documentation regarding the preparation of the medical dose such as, for example, acquiring barcode scans of products, capturing medical dose preparation images of medical dose order receptacles during or after use in the preparation of the dose, or obtaining other information related to the preparation of the dose. In an embodiment, one or more of the types of data described above in relation to the medication dose metadata may be acquired in connection with the preparation of the medical dose order at the work station 40.
At least a portion of the dose metadata obtained 60 regarding the medication dose may be stored for viewing by appropriate personnel (e.g., a pharmacist). In this regard, the 20 dose metadata may be utilized to verify 62 the prepared dose prior to the dose being dispensed from the pharmacy 12. In an embodiment, the metadata collected at the work station 40 may be made available to a pharmacist via a network. In this regard, a pharmacist tasked with verifying 62 a dose order may access the information and/or data remotely (e.g., in a location in the hospital but outside the IV room or even entirely remove from hospital premises via the network). The ability to remotely access the metadata may allow the pharmacist to avoid having to enter the IV room to verify 62 a dose order (i.e., thus avoid the potentially burdensome gowning procedures commonly associated with entering the controlled environment of an IV room). The verifying 62 may include inspection of medical dose preparation images, obtained information, or other data regarding the medical dose order by the pharmacist. For example, the pharmacist may verify the correct medication was prepared in the correct manner and/or in the correct amounts based on metadata gathered and stored during the preparation of the medical dose order. If the medication dose order is incorrect in any regard, the pharmacist may request the medication dose order be reworked or restarted.
Once the dose order has been prepared and verified 62, the medical dose preparation management system 30 may dispense 64 the dose order. When dispensing 64 the dose order, the dose order may be dispatched from the pharmacy 12 for administration to a patient by the care provider. For example, the dose may be administered at the care provider hospital 12 or an offsite location under the direction or supervision of the care provider.
The medical dose preparation management system 30 may also facilitate tracking 66 of the dose order to administration to the patient. The pharmacy work flow manager 30 may also retain records associated with each dose that may be stored or archived. For example, the records may be stored digitally in electronically indexed and searchable form. The records may include at least a portion and preferably all metadata regarding each dose.
With further reference to
The imaging device 80 may include an imaging field 84. The imaging field 84 may encompass a medical dose preparation staging region 86. The imaging device 80 may be supportably mounted to a base 90. For example, a support 92 may extend from the base 90 to the imaging device 80 to support imaging device 80 relative to the base 80. In this regard, in an embodiment the medical dose preparation staging region 86 may include a support surface 94 of the base 90. The medical dose preparation staging region 86 may also include a volume above the surface 94 (e.g., extending from the surface in a direction normal to the surface and/or toward the imaging device 80). In any regard, the imaging field 84 of the imaging device 80 may encompass the medical dose preparation staging region 86 that may supportably receive a medication receptacle 100. In turn, the imaging device 80, support 92, and base 90 may collectively define a camera stand 190. As such, the camera stand 190 may be used at a work station 40 to support the imaging device 80 relative to the base 90 to obtain medical dose preparation image and/or other metadata during the preparation of the medical dose order.
The medication receptacle 100 supportable by the base 90 in the medical dose preparation staging region 86 may include any material, container, apparatus, or other object that is used in the preparation of a dose. For example, the medication receptacle 100 may be or include a source receptacle, a transference receptacle, or an administration receptacle. A source receptacle may store a medication product as stored in the pharmacy prior to compounding or dose preparation. In this regard, the source receptacle may be a receptacle as packaged by and received from a drug manufacturer. As such, the source receptacle may include information thereon relating to the medication. For example, the product name, concentration, amount, lot information, expiration information, a serial number, other manufacturing information or other information may be associated with the medication and/or may appear on the source receptacle. The medical dose preparation management system 30 may be operable to store metadata regarding the source receptacle including any of the foregoing portions of data that may appear on the source receptacle. In this regard, the source receptacle may be identifiable by the work station 40 (e.g., via the use of a machine readable indicium such as a bar code or the like).
Furthermore, the medical dose preparation management system 30 may be operable to attribute metadata from the source receptacle to the dose order in which the source receptacle is used as described above. The source receptacle metadata may even be attributed to or appended to the metadata for the medical dose order when the source receptacle comprises a pre-prepared medication that has been compounded at the pharmacy and disposed in the source receptacle for later use in the preparation of a dose. In this regard, the metadata for several generations of components used to prepare a medical dose order (e.g., originating from original source components received from a manufacturer such as a drug manufacturer) may be attributed to the medical dose order. As such, the medical dose order metadata may include information regarding all components used in the medical dose order including inherited metadata. The metadata for the various components may be retrieved upon identification of the receptacle 100 at the work station 40 (e.g., by way of scanning a machine readable indicium). In various embodiments, the source receptacle may include a vial, a syringe, a bottle, a bag, or other appropriate medication receptacle known in the art.
An administration receptacle may be any receptacle used during the administration of the medical dose to the patient. The administration receptacle may contain any medication, diluent, supplement, or any other material to be administered to the patient. In various embodiments, the administration receptacle may include a syringe, an IV bag, or other appropriate medication receptacle used in the administration of a substance to patient. An administration receptacle may also include metadata that is included in the metadata for the prepared medical dose order.
The transference receptacle may be used to transfer a substance from a source receptacle to the administration receptacle. For example, the transference receptacle may be a syringe or any other appropriate receptacle known in the art capable of transferring a substance from the source receptacle to the administration receptacle. A transference receptacle may also include metadata that is included in the metadata for the prepared medical dose order.
Returning to
The video data stream processing module 72 of the processor 70 may also be operative to capture a medical dose preparation image from the video data stream 82 received from the imaging device 80. Medical dose preparation images captured by the video data stream processing module 72 may include one or more medication receptacles 100 used in the course of preparing a medical dose order. In this regard, the preparation of medical dose orders may be documented by capturing images of the medication receptacles 100 used to prepare the dose. The medical dose preparation images may be stored as metadata regarding the medical dose order. A medical dose preparation image may include one or more medication receptacles at various stages during the preparation of the dose. For example, a source receptacle, a transference receptacle, or an administration receptacle may be imaged before, during or after preparation of the dose.
The medical dose preparation images captured by the video data stream processing module 72 may be stored in a memory 120 in operative communication with the processor 70. In this regard, the medical dose preparation images may be stored locally in the memory 120 at the work station 40. Additionally or alternatively, the medical dose preparation images may be communicated to a remote location (e.g., an on-site medication dose order database 32 or an off-site medication dose order database 34 shown in
The processor 70 may also be in operative communication with a user control device 130. The user control device 130 may be operable to receive an input from a user (e.g., a pharmacy technician preparing a dose). The user control device 130 may be, for example, a foot pedal, a button, a touch screen, a mouse, a keyboard, or other user input device known in the art. A user may utilize the user control device 130 to trigger the capture of a medical dose preparation image from the video data stream 82. For example, a medication receptacle 100 may be viewed by the user by observing the display 110 displaying the video data stream 82 captured by the imaging device 80 of imaging field 86 including the medication receptacle 100. Once the image displayed on the display 110 is acceptable to the user, the user may use the user control device 130 to trigger the capture of the medical dose preparation image for storage in the memory 120 or in a remote database as described above.
The work station 40 may also include a printer 150 that is operative to print dose labels associated with a medical product, a dose that is in progress, and/or a completed dose. In this regard, the printer 150 may be a label printer operative to print labels used in the pharmacy 12 and/or hospital in connection with metal doses and/or medical dose orders.
It may be appreciated that in the course of preparing medical dose orders in a hospital 12, the number of medical dose preparation images captured in connection with dose orders may be extremely large. For example, a plurality of images may be captured in connection with each dose prepared. For most hospitals, the number of doses prepared daily may be on the order of hundreds of doses or more. In this regard, the memory resources necessary to store images captured in connection with the preparation of medical dose orders may be large, especially considering the practice of hospitals of storing archived images for dose orders.
Furthermore, because medical dose preparation images may be used by a pharmacist to verify medical dose orders prior to dispensing orders from the pharmacy, image resolution may be at a premium in order to facilitate accurate review by the pharmacist of images. Accordingly, the need for large memory resources dedicated to storing medical dose preparation images is exacerbated. Accordingly, any reduction in image size (e.g., as represented by the size of the image in memory) may be advantageous to reduce the memory resources required for storage of images and/or to allow more efficient use of memory resources available for the storage of medical dose preparation images.
As such, capturing medical dose preparation images including the entire imaging field 86 may be an inefficient use of memory resources. Cropping images to retain relevant portions of the imaging field 86 (i.e., those containing medication receptacles 100) for storage may be a more efficient use of memory resources than storing an image of the entire imaging field 86. For example, for a given resolution, the overall image dimensions may be reduced to reduce the size in memory of the image. Additionally or alternatively, for an image with reduced overall dimensions, the image resolution may be increased without an increase in the size of the image in memory compared to an image of the entire imaging field 84 at a reduced resolution.
However, requiring an operator to manually crop each image of the imaging field 86 may add time to the preparation of medical dose orders. This may result in increased costs associated with preparation of medical disorders or be undesirable based on scheduling requirements for doses, especially “stat” doses that may be critical to the life of a patient. In this regard, the video data stream processing module 72 may be operative to perform an auto cropping operation on the video data stream 82 acquired by the imaging device 80 so as to identify relevant portions of the video data stream 82 for storage to reduce the memory resources needed to store medical dose preparation images while not impacting the speed of the preparation of medical dose orders.
In an embodiment, an auto cropping operation may involve comparing the video data stream 82 with a background image to identify a region of interest corresponding to an object disposed in the imaging field in the video data stream 82. With further reference to
In an embodiment, a plurality of background images 200 may be obtained such that different ones of the plurality of background images 200 are employed in the auto cropping operation depending upon the location and/or orientation of the imaging device 80. For example, the imaging device 80 may be positionable in a plurality of positions. Accordingly, depending upon the position of the imaging device 80, the background image 200 may differ.
In this regard, a sensor may be provided to determine the position in which the imaging device 80 disposed such an appropriate corresponding one of the plurality of background images may be used based on the identified position of the imaging device 80.
In any regard, after a background image 200 has been attained, one or more medication receptacles 100 may be disposed in the medical dose preparation staging region 86 as depicted in
In this regard, upon analysis of the differences between the background image 200 and video data stream 82, a plurality of locations representing differences between the video data stream 82 and the background image 200 corresponding to the medication receptacles
20
100 may be determined such that regions of interest encompassing the medication receptacles 100 may be determined. In turn, the medical dose preparation images captured may contain image data corresponding only to the regions of interest identified including the medication receptacles 100 and may exclude a portion or all of the imaging field 86 outside the region of interest.
25 In an embodiment, a subset (e.g., a predetermined subset) of the video data stream
82 may be compared to a corresponding subset of the background image 200 to identify differences between the video data stream 82 and the background image 200 corresponding to the presence of medication receptacles 100. By comparing only a subset of the video data stream 82 against a corresponding subset of the background image 200, the amount of data to be processed may be reduced such that the auto cropping operation may occur more quickly to prevent the slowing of the preparation of medical doses.
In this regard, the auto cropping operation described herein may occur substantially faster than a method where every pixel of an image is analyzed to determine differences between a video data stream 82 and a background image 200. As such, the auto crop operation described herein may provide an accurate automatic crop operation with a very fast execution time. For example, the auto crop operation described herein may occur for a given frame of the video data stream 82 prior to obtaining the next frame in the video data stream 82. For example, in the embodiment where the imaging device 80 to collects video at 5-10 frames per second, the auto cropping operation may be completed faster than the frame rate of the imaging device 80 (i.e., at least within 100 ms for a frame rate of 10 frames/second). That is, the auto cropping algorithm may execute in a time less than the refresh rate of the video data stream. In this regard, the auto cropping operation may identify a region of interest for each image in the video data stream 82 prior to obtaining the next image in the video data stream 82.
With reference to
The grid lines 210 and 212 may extend in at least two directions over the imaging field such that the length and the width of a region of interest may be determined relative to the grid lines 210 and 212. With further reference
The grid spacing of the predetermined portion of the video data stream 82 and the background image 200 may be selected based on the smallest object anticipated to be imaged. For example, the spacing of the grid lines 210, 212 may be selected such that the least two grid lines 210, 212 cross any medication receptacle 100 that may be placed in the medical dose preparation staging region 86 such that the extent of the bounding area may be accurately determined for each medication receptacle 100.
With additional reference to
The video data stream processing module 72 may extract color bitmap data along the horizontal line 300. The video data stream processing module 72 may convert the data for each pixel taken along the horizontal line 300 into an array of grayscale data corresponding to intensity data for each pixel. In one embodiment, the video data stream processing module 72 may convert grayscale data for each pixel into a quantitative value representing the relative color of the grayscale data for each pixel between white and black. For example, an 8 bit value may be established on a scale of 0-255 where zero represents black and 255 represents white for a pixel. Accordingly, the intensity data for each pixel may correspond to a value representative of the pixels location in the grayscale between white and black.
Various processing techniques may be applied to the intensity data of the pixels taken along the horizontal line. For example, a transform of the data into the frequency domain using a mathematical transform (e.g., fast Fourier transform (FFT)) may be applied to the intensity data.
As can be appreciated from
With further reference to
However,
Furthermore, processing may be performed on the intensity data for each pixel to assist in improving the accuracy of the auto cropping operation. For example, the intensity data may be filtered using any number of additional or alternative filtering techniques known the art.
Additionally, the rate of change of the intensity along each grid line 210, 212 rather than raw intensity data for each pixel may provide a more accurate measure of the presence or absence of a medication receptacle 100 disposed in a medical dose preparation staging region 86. In this regard, the derivative of the raw intensity data 320 may be calculated to reflect the rate of change of intensity along each grid line 210, 212 to assist in determining the location of an edge of a medication receptacle 100 disposed in the medical dose preparation staging region 86.
Furthermore, during the correlation of the subset of the video data stream 82 with the background image 200, each pixel of the video data stream 82 may be compared to a directly corresponding pixel in the background image 200 or each pixel of the video data stream 82 may be compared to a plurality of pixels within a certain predetermined distance along the corresponding grid line in the background image 200 of a directly corresponding pixel. For example, any given pixel for the video data stream 82 may be compared to pixels within about +/−10 pixels of the directly corresponding pixel in the background image 200. Thus, slight variations between the position of the background image 200 relative to the video data stream 82 and/or minor lighting variations may be accommodated that may otherwise be attributed to identified edges of medication receptacles 100. For example, the video data stream 82 corresponding to the background image 200 may move slightly and/or be subject to slightly different lighting such that minor variations may occur. However, by comparing a given pixel in the video data stream 82 with a range of pixels in the corresponding background image 200, and minor variations may be accounted for.
Based on the analysis of the video data stream 82 in relation to the background image 200, the edges of a given medication receptacle 100 may be determined along each grid line 210, 212. For example, a difference identified along a grid line 210, 212 that exceeds a predetermined rate of change may be attributed to a location 370 of an edge of a medication receptacle 100. Based on the locations 370 at each grid line 210, 212 corresponding to determined edges of medication receptacles 100, a bounding area 360 (e.g., as shown in
With further reference to
As may further be appreciated in
In this regard, the auto cropping operation may include logic to individually identify different medication receptacles 100 disposed in imaging field 86. For example, logic may be employed wherein if a certain predetermined distance along a grid line 210, 212 does not have any differences compared to the background image 200, the locations 370 at the extends of a distance exceeding the predetermined distance may be attributed to separate medication receptacles 100. Additionally or alternatively, an analysis may be performed to identify a perimeter of a medication receptacle 100 such that individual medical receptacles 100 may be identified based on identification of a unitary closed perimeter. For example, for a given close perimeter, the auto cropping operation may determine a single medication receptacle 100 exists and dedicate a single bounding box to the identified medical receptacle 100.
With further reference
The user may have the opportunity to expand or contract the bounding area 360 displayed to increase or decrease the size of the region of interest surrounding a medication receptacle 100 in the video data stream 82. In an embodiment, if the bounding box 320 is incorrectly determined by the auto cropping operation the user may employ a marker or other object disposed in the medical dose preparation staging area 86 that provides a high contrast to the background 200 to establish an edge location 370 for a bounding area 360. For example, an object may be disposed adjacent to the medication receptacle 100 to positively establish an edge 362 of the bounding area 360 beyond the extent of the medication receptacle 100. The object may be a discrete object such as a marker or the like that is placed in the imaging field 86, or the user may employ his or her finger or other pointing device disposed in imaging field 86 to positively establish a location 370.
Once the region of interest has been established by the user, the user may utilize the user control device 130 to initiate the capture of medical dose preparation images corresponding to the portion of the video data stream 82 included in the bounding box 320 (i.e., the region of interest). For example,
In an embodiment, the bounding area 360 may be represented a box superimposed over the video data stream 82 in a manner perceivable by the user. Additionally or alternatively, the area outside the bounding area 360 not to be included in the medical dose preparation image may be displayed in a manner different than the area within the bounding area 360 to be included in the medical dose preparation image. For example, the area of the imaging field 86 outside a bounding area 360 may be displayed as a dimmed or shadowed image that clearly identifies to the user that the area outside the bounding areas 360 is to be not included in the medical dose preparation image.
While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description is to be considered as exemplary and not restrictive in character. For example, certain embodiments described hereinabove may be combinable with other described embodiments and/or arranged in other ways (e.g., process elements may be performed in other sequences). Accordingly, it should be understood that only the preferred embodiment and variants thereof have been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
The foregoing description of the present invention has been presented for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the form disclosed herein. Consequently, variations and modifications commensurate with the above teachings, and skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described hereinabove are further intended to explain known modes of practicing the invention and to enable others skilled in the art to utilize the invention in such or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention. It is intended that the appended claims be construed to include alternative embodiments to the extent permitted by the prior art.
This application is a continuation of U.S. patent application Ser. No. 15/339,390, filed Oct. 31, 2016, entitled “IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which is a continuation of U.S. patent application Ser. No. 14/438,544, filed Apr. 24, 2015, now U.S. Pat. No. 9,489,489, entitled “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which is a U.S. National Stage of International Patent Application No. PCT/US2013/032497, filed Mar. 15, 2013, entitled, “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which claims benefit of priority to U.S. Provisional Patent Application No. 61/719,235 filed Oct. 26, 2012, entitled “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” all of which foregoing patent applications are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
641748 | Smith | Jan 1900 | A |
819339 | Cleland | May 1906 | A |
3426150 | Tygart | Feb 1969 | A |
3739943 | Williamsen et al. | Jun 1973 | A |
3742938 | Stern | Jul 1973 | A |
3756752 | Stenner | Sep 1973 | A |
3774762 | Lichtenstein | Nov 1973 | A |
3786190 | Pori | Jan 1974 | A |
3809871 | Howard et al. | May 1974 | A |
3810102 | Parks, III et al. | May 1974 | A |
3848112 | Weichselbaum et al. | Nov 1974 | A |
3858574 | Page | Jan 1975 | A |
3878967 | Joslin et al. | Apr 1975 | A |
3910257 | Fletcher et al. | Oct 1975 | A |
3910260 | Sarnoff et al. | Nov 1975 | A |
3921196 | Patterson | Nov 1975 | A |
3971000 | Cromwell | Jul 1976 | A |
3995630 | Verrdonk | Dec 1976 | A |
3998103 | Bjorklund et al. | Dec 1976 | A |
4032908 | Rice et al. | Jun 1977 | A |
4078562 | Friedman | Mar 1978 | A |
4144496 | Cunningham et al. | Mar 1979 | A |
4151407 | McBride et al. | Apr 1979 | A |
4156867 | Bench et al. | May 1979 | A |
4164320 | Irazoqui et al. | Aug 1979 | A |
4173971 | Karz | Nov 1979 | A |
4199307 | Jassawalla | Apr 1980 | A |
4270532 | Franetzki et al. | Jun 1981 | A |
4273121 | Jassawalla | Jun 1981 | A |
4282872 | Franetzki et al. | Aug 1981 | A |
4308866 | Jelliffe et al. | Jan 1982 | A |
4319338 | Grudowski et al. | Mar 1982 | A |
4320757 | Whitney et al. | Mar 1982 | A |
4354252 | Lamb et al. | Oct 1982 | A |
4369780 | Sakai | Jan 1983 | A |
4370983 | Lichtenstein | Feb 1983 | A |
4373527 | Fischell | Feb 1983 | A |
4381776 | Latham, Jr. | May 1983 | A |
4385630 | Gilcher et al. | May 1983 | A |
4398289 | Schoate | Aug 1983 | A |
4398908 | Siposs | Aug 1983 | A |
4414566 | Peyton et al. | Nov 1983 | A |
4416654 | Schoendorfer et al. | Nov 1983 | A |
4425114 | Schoendorfer et al. | Jan 1984 | A |
4428381 | Hepp | Jan 1984 | A |
4443216 | Chappell | Apr 1984 | A |
4447224 | DeCant, Jr. et al. | May 1984 | A |
4449538 | Corbitt et al. | May 1984 | A |
4451255 | Bujan et al. | May 1984 | A |
4457750 | Hill | Jul 1984 | A |
4458693 | Badzinski et al. | Jul 1984 | A |
4460358 | Somerville et al. | Jul 1984 | A |
4464172 | Lichtenstein | Aug 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4476381 | Rubin | Oct 1984 | A |
4480751 | Lueptow | Nov 1984 | A |
4481670 | Freeburg | Nov 1984 | A |
4487604 | Iwatschenko et al. | Dec 1984 | A |
4490798 | Franks et al. | Dec 1984 | A |
4496351 | Hillel et al. | Jan 1985 | A |
4511352 | Theeuwes et al. | Apr 1985 | A |
4525861 | Freeburg | Jun 1985 | A |
4526574 | Pekkarinen | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
4538138 | Harvey et al. | Aug 1985 | A |
4545071 | Freeburg | Oct 1985 | A |
4551133 | Zegers de Beyl et al. | Nov 1985 | A |
4559038 | Berg et al. | Dec 1985 | A |
4560979 | Rosskopf | Dec 1985 | A |
4561443 | Hogrefe et al. | Dec 1985 | A |
4562751 | Nason | Jan 1986 | A |
4564054 | Gustaysson | Jan 1986 | A |
4590473 | Burke et al. | May 1986 | A |
4602249 | Abbott | Jul 1986 | A |
4619653 | Fischell | Oct 1986 | A |
4622979 | Katchis et al. | Nov 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4636950 | Caswell et al. | Jan 1987 | A |
4637817 | Archibald et al. | Jan 1987 | A |
4650469 | Berg et al. | Mar 1987 | A |
4652262 | Veracchi | Mar 1987 | A |
4653010 | Figler et al. | Mar 1987 | A |
4676776 | Howson | Jun 1987 | A |
4681563 | Deckert et al. | Jul 1987 | A |
4688167 | Agarwal | Aug 1987 | A |
4691580 | Fosslien | Sep 1987 | A |
4695954 | Rose et al. | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4697928 | Csongor | Oct 1987 | A |
4702595 | Mutschler et al. | Oct 1987 | A |
4705506 | Archibald | Nov 1987 | A |
D293135 | Medema et al. | Dec 1987 | S |
4714462 | DiComenico | Dec 1987 | A |
4717042 | McLaughlin | Jan 1988 | A |
4718576 | Tamura et al. | Jan 1988 | A |
4722224 | Scheller et al. | Feb 1988 | A |
4722349 | Baumberg | Feb 1988 | A |
4722734 | Kolln | Feb 1988 | A |
4730849 | Siegel | Mar 1988 | A |
4731058 | Doan | Mar 1988 | A |
4732411 | Siegel | Mar 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4741736 | Brown | May 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4759756 | Forman | Jul 1988 | A |
4770184 | Greene et al. | Sep 1988 | A |
4778449 | Weber et al. | Oct 1988 | A |
4779626 | Peel et al. | Oct 1988 | A |
4784645 | Fischell | Nov 1988 | A |
4785799 | Schoon et al. | Nov 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4796644 | Polaschegg | Jan 1989 | A |
4797840 | Fraden | Jan 1989 | A |
4803625 | Fu et al. | Feb 1989 | A |
4810090 | Boucher | Mar 1989 | A |
4810243 | Howson | Mar 1989 | A |
4811844 | Moulding, Jr. et al. | Mar 1989 | A |
4816208 | Woods et al. | Mar 1989 | A |
4817044 | Ogren | Mar 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4829524 | Yoshida | May 1989 | A |
4830018 | Treach | May 1989 | A |
4831562 | Mcintosh et al. | May 1989 | A |
4832033 | Maher et al. | May 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4835521 | Andrejasich et al. | May 1989 | A |
4838275 | Lee | Jun 1989 | A |
4839806 | Goldfischer et al. | Jun 1989 | A |
4845644 | Anthias et al. | Jul 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4850009 | Zook et al. | Jul 1989 | A |
4850972 | Schulman et al. | Jul 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4854324 | Hirschman et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4878175 | Norden-Paul et al. | Oct 1989 | A |
4880013 | Chio | Nov 1989 | A |
4889132 | Hutcheson et al. | Dec 1989 | A |
4889134 | Greenwold et al. | Dec 1989 | A |
4893270 | Beck et al. | Jan 1990 | A |
4897777 | Janke et al. | Jan 1990 | A |
4898209 | Zbed | Feb 1990 | A |
4898576 | Philip | Feb 1990 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4901728 | Hutchison | Feb 1990 | A |
4905163 | Garber et al. | Feb 1990 | A |
4908017 | Howson et al. | Mar 1990 | A |
4912623 | Rantala et al. | Mar 1990 | A |
4916441 | Gombrich et al. | Apr 1990 | A |
4922922 | Pollock et al. | May 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4933843 | Scheller et al. | Jun 1990 | A |
4937777 | Flood et al. | Jun 1990 | A |
4941808 | Qureshi et al. | Jul 1990 | A |
4943279 | Samiotes et al. | Jul 1990 | A |
4943987 | Asahina et al. | Jul 1990 | A |
4946445 | Lynn | Aug 1990 | A |
4949274 | Hollander et al. | Aug 1990 | A |
4952928 | Carroll et al. | Aug 1990 | A |
4953074 | Kametani et al. | Aug 1990 | A |
4960230 | Marelli | Oct 1990 | A |
4964847 | Prince | Oct 1990 | A |
4966579 | Polaschegg | Oct 1990 | A |
4967928 | Carter | Nov 1990 | A |
4968295 | Neumann | Nov 1990 | A |
4975647 | Downer et al. | Dec 1990 | A |
4977590 | Milovancevic | Dec 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
4991091 | Allen | Feb 1991 | A |
4992926 | Janke et al. | Feb 1991 | A |
4993068 | Piosenka et al. | Feb 1991 | A |
4993506 | Angel | Feb 1991 | A |
4998249 | Bennett et al. | Mar 1991 | A |
5002055 | Merki et al. | Mar 1991 | A |
5003296 | Lee | Mar 1991 | A |
5006699 | Felkner et al. | Apr 1991 | A |
5007429 | Treatch et al. | Apr 1991 | A |
5012402 | Akiyama | Apr 1991 | A |
5012411 | Policastro et al. | Apr 1991 | A |
5014875 | McLaughlin et al. | May 1991 | A |
5016172 | Dessertine | May 1991 | A |
5023770 | Siverling | Jun 1991 | A |
5025374 | Roizen et al. | Jun 1991 | A |
5036852 | Leishman | Aug 1991 | A |
5038800 | Oba | Aug 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5045048 | Kaleskas et al. | Sep 1991 | A |
5047959 | Phillips et al. | Sep 1991 | A |
5053031 | Borsanyi | Oct 1991 | A |
5053990 | Kreifels et al. | Oct 1991 | A |
5055001 | Natwick et al. | Oct 1991 | A |
5057076 | Polaschegg | Oct 1991 | A |
5061243 | Winchell et al. | Oct 1991 | A |
5072356 | Watt et al. | Dec 1991 | A |
5072383 | Brimm et al. | Dec 1991 | A |
5072412 | Henderson, Jr. et al. | Dec 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5084828 | Kaufman et al. | Jan 1992 | A |
5087245 | Doan | Feb 1992 | A |
5088904 | Okada | Feb 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5088990 | Hivale et al. | Feb 1992 | A |
5096385 | Georgi et al. | Mar 1992 | A |
5098377 | Borsanyi et al. | Mar 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5100394 | Dudar et al. | Mar 1992 | A |
5103211 | Daoud et al. | Apr 1992 | A |
5104374 | Bishko et al. | Apr 1992 | A |
5108131 | Nassim | Apr 1992 | A |
5108363 | Tuttle et al. | Apr 1992 | A |
5108367 | Epstein et al. | Apr 1992 | A |
5108372 | Swenson | Apr 1992 | A |
5109487 | Ohgomori et al. | Apr 1992 | A |
5109849 | Goodman et al. | May 1992 | A |
5112319 | Lai | May 1992 | A |
5116203 | Natwick et al. | May 1992 | A |
5116312 | Blankenship et al. | May 1992 | A |
5131092 | Sackmann et al. | Jul 1992 | A |
5134574 | Beaverstock et al. | Jul 1992 | A |
5135500 | Zdeb | Aug 1992 | A |
5137023 | Mendelson et al. | Aug 1992 | A |
5151978 | Bronikowski et al. | Sep 1992 | A |
5152296 | Simons | Oct 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5155693 | Altmayer et al. | Oct 1992 | A |
5157595 | Lovrenich | Oct 1992 | A |
5158091 | Butterfield et al. | Oct 1992 | A |
5159673 | Sackmann et al. | Oct 1992 | A |
5160320 | Yum et al. | Nov 1992 | A |
5161211 | Taguchi et al. | Nov 1992 | A |
5167235 | Seacord et al. | Dec 1992 | A |
5169642 | Brinker et al. | Dec 1992 | A |
5172698 | Stanko | Dec 1992 | A |
5176004 | Gaudet | Jan 1993 | A |
5179569 | Sawyer | Jan 1993 | A |
5179700 | Aihara et al. | Jan 1993 | A |
5181910 | Scanlon | Jan 1993 | A |
5190185 | Blechl | Mar 1993 | A |
5190522 | Wojcicki et al. | Mar 1993 | A |
5191891 | Righter | Mar 1993 | A |
5208762 | Charhut et al. | May 1993 | A |
5208907 | Shelton et al. | May 1993 | A |
5211849 | Kitaevich et al. | May 1993 | A |
5213099 | Tripp, Jr. | May 1993 | A |
5213232 | Kraft et al. | May 1993 | A |
5213568 | Lattin et al. | May 1993 | A |
5219330 | Bollish et al. | Jun 1993 | A |
5219331 | Vanderveen | Jun 1993 | A |
5225974 | Mathews et al. | Jul 1993 | A |
5226425 | Righter | Jul 1993 | A |
5228450 | Sellers | Jul 1993 | A |
5231990 | Gauglitz | Aug 1993 | A |
5234404 | Tuttle et al. | Aug 1993 | A |
5235510 | Yamada et al. | Aug 1993 | A |
5236416 | McDaniel et al. | Aug 1993 | A |
5238001 | Gallant et al. | Aug 1993 | A |
5240007 | Pytel et al. | Aug 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5245704 | Weber et al. | Sep 1993 | A |
5254096 | Rondelet et al. | Oct 1993 | A |
5256156 | Kern et al. | Oct 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5261884 | Stern et al. | Nov 1993 | A |
5262943 | Thibado et al. | Nov 1993 | A |
5265010 | Evans-Paganelli et al. | Nov 1993 | A |
5265431 | Gaudet et al. | Nov 1993 | A |
5267174 | Kaufman et al. | Nov 1993 | A |
5271405 | Boyer et al. | Dec 1993 | A |
5272318 | Gorman | Dec 1993 | A |
5272321 | Otsuka et al. | Dec 1993 | A |
5273517 | Barone et al. | Dec 1993 | A |
5277188 | Selker | Jan 1994 | A |
5283861 | Dangler et al. | Feb 1994 | A |
5284150 | Butterfield et al. | Feb 1994 | A |
5286252 | Tuttle et al. | Feb 1994 | A |
5292029 | Pearson | Mar 1994 | A |
5297257 | Struger et al. | Mar 1994 | A |
5298021 | Sherer | Mar 1994 | A |
5304126 | Epstein et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5307372 | Sawyer et al. | Apr 1994 | A |
5307463 | Hyatt et al. | Apr 1994 | A |
5311908 | Barone et al. | May 1994 | A |
5314243 | McDonald et al. | May 1994 | A |
5315505 | Pratt et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
5319363 | Welch et al. | Jun 1994 | A |
5319543 | Wilhelm | Jun 1994 | A |
5321618 | Gessman | Jun 1994 | A |
5321829 | Zifferer | Jun 1994 | A |
5324422 | Colleran et al. | Jun 1994 | A |
5325478 | Shelton et al. | Jun 1994 | A |
5327341 | Whalen et al. | Jul 1994 | A |
5331549 | Crawford, Jr. | Jul 1994 | A |
5336245 | Adams et al. | Aug 1994 | A |
5337230 | Baumgartner et al. | Aug 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5337919 | Spaulding et al. | Aug 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5339421 | Housel, III | Aug 1994 | A |
5339821 | Fujimoto | Aug 1994 | A |
5341291 | Roizen et al. | Aug 1994 | A |
5341412 | Ramot et al. | Aug 1994 | A |
5348008 | Bornn et al. | Sep 1994 | A |
5348539 | Herskowitz | Sep 1994 | A |
5349675 | Fitzgerald et al. | Sep 1994 | A |
5356378 | Doan | Oct 1994 | A |
5360410 | Wacks | Nov 1994 | A |
5361202 | Doue | Nov 1994 | A |
5361758 | Hall et al. | Nov 1994 | A |
5366896 | Margrey et al. | Nov 1994 | A |
5366904 | Qureshi et al. | Nov 1994 | A |
5367555 | Isoyama | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5370612 | Maeda et al. | Dec 1994 | A |
5371687 | Holmes, II et al. | Dec 1994 | A |
5374251 | Smith | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
5374965 | Kanno | Dec 1994 | A |
5375604 | Kelly et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5377864 | Blechl et al. | Jan 1995 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5379214 | Arbuckle et al. | Jan 1995 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5390238 | Kirk et al. | Feb 1995 | A |
5392951 | Gardner et al. | Feb 1995 | A |
5395320 | Padda et al. | Mar 1995 | A |
5395321 | Kawahara et al. | Mar 1995 | A |
5398336 | Tantry et al. | Mar 1995 | A |
5401059 | Ferrario | Mar 1995 | A |
5404292 | Hendrickson | Apr 1995 | A |
5404384 | Colburn et al. | Apr 1995 | A |
5406473 | Yoshikura et al. | Apr 1995 | A |
5412715 | Volpe | May 1995 | A |
5415167 | Wilk | May 1995 | A |
5416695 | Stutman et al. | May 1995 | A |
5417222 | Dempsey et al. | May 1995 | A |
5420977 | Sztipanovits et al. | May 1995 | A |
5421343 | Feng | Jun 1995 | A |
5423746 | Burkett et al. | Jun 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5431201 | Torchia et al. | Jul 1995 | A |
5431299 | Brewer et al. | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5433736 | Nilsson | Jul 1995 | A |
5438607 | Przygoda, Jr. et al. | Aug 1995 | A |
5440699 | Farrand et al. | Aug 1995 | A |
5441047 | David et al. | Aug 1995 | A |
5445294 | Gardner et al. | Aug 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5446868 | Gardea, II et al. | Aug 1995 | A |
5453098 | Botts et al. | Sep 1995 | A |
5455851 | Chaco et al. | Oct 1995 | A |
5458123 | Unger | Oct 1995 | A |
5460294 | Williams | Oct 1995 | A |
5460605 | Tuttle et al. | Oct 1995 | A |
5461665 | Shur et al. | Oct 1995 | A |
5462051 | Oka et al. | Oct 1995 | A |
5464392 | Epstein et al. | Nov 1995 | A |
5465286 | Clare et al. | Nov 1995 | A |
5467773 | Bergelson et al. | Nov 1995 | A |
5468110 | McDonald et al. | Nov 1995 | A |
5469855 | Pompei et al. | Nov 1995 | A |
5471382 | Tallman et al. | Nov 1995 | A |
5474552 | Palti | Dec 1995 | A |
5482043 | Zulauf | Jan 1996 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5490610 | Pearson | Feb 1996 | A |
5494592 | Latham, Jr. et al. | Feb 1996 | A |
5496265 | Langley et al. | Mar 1996 | A |
5496273 | Pastrone et al. | Mar 1996 | A |
5502944 | Kraft et al. | Apr 1996 | A |
5507412 | Ebert et al. | Apr 1996 | A |
5508912 | Schneiderman | Apr 1996 | A |
5509318 | Gomes | Apr 1996 | A |
5509422 | Fukami | Apr 1996 | A |
5513957 | O'Leary | May 1996 | A |
5514088 | Zakko | May 1996 | A |
5514095 | Brightbill et al. | May 1996 | A |
5515426 | Yacenda et al. | May 1996 | A |
5520450 | Colson, Jr. et al. | May 1996 | A |
5520637 | Pager et al. | May 1996 | A |
5522396 | Langer et al. | Jun 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5526428 | Arnold | Jun 1996 | A |
5528503 | Moore et al. | Jun 1996 | A |
5529063 | Hill | Jun 1996 | A |
5531680 | Dumas et al. | Jul 1996 | A |
5531697 | Olsen et al. | Jul 1996 | A |
5531698 | Olsen | Jul 1996 | A |
5533079 | Colburn et al. | Jul 1996 | A |
5533981 | Mandro et al. | Jul 1996 | A |
5534691 | Holdaway et al. | Jul 1996 | A |
5536084 | Curtis et al. | Jul 1996 | A |
5537313 | Pirelli | Jul 1996 | A |
5537853 | Finburgh et al. | Jul 1996 | A |
5542420 | Goldman et al. | Aug 1996 | A |
5544649 | David et al. | Aug 1996 | A |
5544651 | Wilk | Aug 1996 | A |
5544661 | Davis et al. | Aug 1996 | A |
5545140 | Conero et al. | Aug 1996 | A |
5546580 | Seliger et al. | Aug 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5549117 | Tacklind et al. | Aug 1996 | A |
5549460 | O'Leary | Aug 1996 | A |
5553609 | Chen et al. | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5558640 | Pfeiler et al. | Sep 1996 | A |
5560352 | Heim et al. | Oct 1996 | A |
5562232 | Pearson | Oct 1996 | A |
5562621 | Claude et al. | Oct 1996 | A |
5563347 | Martin et al. | Oct 1996 | A |
5564434 | Halperin et al. | Oct 1996 | A |
5564803 | McDonald et al. | Oct 1996 | A |
5568912 | Minami et al. | Oct 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5569187 | Kaiser | Oct 1996 | A |
5571258 | Pearson | Nov 1996 | A |
5573502 | LeCocq et al. | Nov 1996 | A |
5573506 | Vasko | Nov 1996 | A |
5575632 | Morris et al. | Nov 1996 | A |
5576952 | Stutman et al. | Nov 1996 | A |
5579001 | Dempsey et al. | Nov 1996 | A |
5579378 | Arlinghaus, Jr. | Nov 1996 | A |
5581369 | Righter et al. | Dec 1996 | A |
5581687 | Lyle et al. | Dec 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5583758 | Mcilroy et al. | Dec 1996 | A |
5588815 | Zaleski, II | Dec 1996 | A |
5589932 | Garcia-Rubio et al. | Dec 1996 | A |
5590648 | Mitchell et al. | Jan 1997 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5593267 | McDonald et al. | Jan 1997 | A |
5594637 | Eisenberg et al. | Jan 1997 | A |
5594786 | Chaco et al. | Jan 1997 | A |
5597995 | Williams et al. | Jan 1997 | A |
5598536 | Slaughter, III et al. | Jan 1997 | A |
5601445 | Schipper et al. | Feb 1997 | A |
5609575 | Larson et al. | Mar 1997 | A |
5609576 | Voss et al. | Mar 1997 | A |
5613115 | Gihl et al. | Mar 1997 | A |
5619428 | Lee et al. | Apr 1997 | A |
5619991 | Sloane | Apr 1997 | A |
5623652 | Vora et al. | Apr 1997 | A |
5623925 | Swenson et al. | Apr 1997 | A |
5626144 | Tacklind et al. | May 1997 | A |
5628619 | Wilson | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5631844 | Margrey et al. | May 1997 | A |
5633910 | Cohen | May 1997 | A |
D380260 | Hyman | Jun 1997 | S |
5634893 | Rishton | Jun 1997 | A |
5637082 | Pages et al. | Jun 1997 | A |
5637093 | Hyman et al. | Jun 1997 | A |
5640301 | Roecher et al. | Jun 1997 | A |
5640953 | Bishop et al. | Jun 1997 | A |
5641628 | Bianchi | Jun 1997 | A |
5643193 | Papillon et al. | Jul 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5647853 | Feldmann et al. | Jul 1997 | A |
5647854 | Olsen et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5652566 | Lambert | Jul 1997 | A |
5658240 | Urdahl et al. | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5661978 | Holmes et al. | Sep 1997 | A |
5664270 | Bell et al. | Sep 1997 | A |
5666404 | Ciccotelli et al. | Sep 1997 | A |
D385646 | Chan | Oct 1997 | S |
5678562 | Sellers | Oct 1997 | A |
5678568 | Uchikubo et al. | Oct 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5682526 | Smokoff et al. | Oct 1997 | A |
5683367 | Jordan et al. | Nov 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5687717 | Halpern | Nov 1997 | A |
5687734 | Dempsey et al. | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5697951 | Harpstead | Dec 1997 | A |
5700998 | Palti | Dec 1997 | A |
5701894 | Cherry et al. | Dec 1997 | A |
5704351 | Mortara et al. | Jan 1998 | A |
5704364 | Saltzstein et al. | Jan 1998 | A |
5704366 | Tacklind et al. | Jan 1998 | A |
5712798 | Langley et al. | Jan 1998 | A |
5712912 | Tomko et al. | Jan 1998 | A |
5713485 | Liff et al. | Feb 1998 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5715823 | Wood et al. | Feb 1998 | A |
5716114 | Holmes et al. | Feb 1998 | A |
5716194 | Butterfield et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
RE35743 | Pearson | Mar 1998 | E |
5724025 | Tavori | Mar 1998 | A |
5724580 | Levin et al. | Mar 1998 | A |
5732709 | Tacklind et al. | Mar 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5735887 | Barreras, Sr. et al. | Apr 1998 | A |
5737539 | Edelson et al. | Apr 1998 | A |
5740185 | Bosse | Apr 1998 | A |
5740800 | Hendrickson et al. | Apr 1998 | A |
5745366 | Higham et al. | Apr 1998 | A |
5745378 | Barker et al. | Apr 1998 | A |
5752917 | Fuchs | May 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5755563 | Clegg et al. | May 1998 | A |
5758095 | Albaum et al. | May 1998 | A |
5764923 | Tallman et al. | Jun 1998 | A |
5766155 | Hyman et al. | Jun 1998 | A |
5769811 | Stacey et al. | Jun 1998 | A |
5771657 | Lasher et al. | Jun 1998 | A |
5772585 | Lavin et al. | Jun 1998 | A |
5772586 | Heinonen et al. | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5772637 | Heinzmann et al. | Jun 1998 | A |
5776057 | Swenson et al. | Jul 1998 | A |
5778345 | McCartney | Jul 1998 | A |
5778882 | Raymond et al. | Jul 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5782878 | Morgan et al. | Jul 1998 | A |
5785650 | Akasaka et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5788851 | Kenley et al. | Aug 1998 | A |
5790409 | Fedor et al. | Aug 1998 | A |
5791342 | Woodard | Aug 1998 | A |
5791880 | Wilson | Aug 1998 | A |
5793861 | Haigh | Aug 1998 | A |
5793969 | Kamentsky et al. | Aug 1998 | A |
5795317 | Brierton et al. | Aug 1998 | A |
5795327 | Wilson et al. | Aug 1998 | A |
5797515 | Liff et al. | Aug 1998 | A |
5800387 | Duffy et al. | Sep 1998 | A |
5801755 | Echerer | Sep 1998 | A |
5803906 | Pratt et al. | Sep 1998 | A |
5805442 | Crater et al. | Sep 1998 | A |
5805454 | Valerino et al. | Sep 1998 | A |
5805456 | Higham et al. | Sep 1998 | A |
5805505 | Zheng et al. | Sep 1998 | A |
5807321 | Stoker et al. | Sep 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5810747 | Brudny et al. | Sep 1998 | A |
5812410 | Lion et al. | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5815566 | Ramot et al. | Sep 1998 | A |
5818528 | Roth et al. | Oct 1998 | A |
5822418 | Yacenda et al. | Oct 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5823949 | Goltra | Oct 1998 | A |
5826237 | Macrae et al. | Oct 1998 | A |
5829438 | Gibbs et al. | Nov 1998 | A |
5832447 | Rieker et al. | Nov 1998 | A |
5832448 | Brown | Nov 1998 | A |
5832450 | Myers et al. | Nov 1998 | A |
5833599 | Schrier et al. | Nov 1998 | A |
5835897 | Dang | Nov 1998 | A |
5836910 | Duffy et al. | Nov 1998 | A |
5841975 | Layne et al. | Nov 1998 | A |
5842841 | Danby et al. | Dec 1998 | A |
5842976 | Williamson | Dec 1998 | A |
5845253 | Rensimer et al. | Dec 1998 | A |
5848593 | McGrady et al. | Dec 1998 | A |
5851186 | Wood et al. | Dec 1998 | A |
5852590 | De La Huerga | Dec 1998 | A |
5853387 | Clegg et al. | Dec 1998 | A |
5855550 | Lai et al. | Jan 1999 | A |
5857967 | Frid et al. | Jan 1999 | A |
5859972 | Subramaniam et al. | Jan 1999 | A |
5865745 | Schmitt et al. | Feb 1999 | A |
5865786 | Sibalis et al. | Feb 1999 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5876926 | Beecham | Mar 1999 | A |
5880443 | McDonald et al. | Mar 1999 | A |
5882338 | Gray | Mar 1999 | A |
5883370 | Walker et al. | Mar 1999 | A |
5883576 | De La Huerga | Mar 1999 | A |
5884273 | Sattizahn et al. | Mar 1999 | A |
5884457 | Ortiz et al. | Mar 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5891035 | Wood et al. | Apr 1999 | A |
5891734 | Gill et al. | Apr 1999 | A |
5893697 | Zimi et al. | Apr 1999 | A |
5894273 | Meador et al. | Apr 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5897493 | Brown | Apr 1999 | A |
5897530 | Jackson | Apr 1999 | A |
5897989 | Beecham | Apr 1999 | A |
5899665 | Makino et al. | May 1999 | A |
5899855 | Brown | May 1999 | A |
5901150 | Jhuboo et al. | May 1999 | A |
5904668 | Hyman et al. | May 1999 | A |
5905653 | Higham et al. | May 1999 | A |
5907291 | Chen et al. | May 1999 | A |
5907493 | Boyer et al. | May 1999 | A |
5908027 | Butterfield et al. | Jun 1999 | A |
5910107 | Iliff | Jun 1999 | A |
5910252 | Truitt et al. | Jun 1999 | A |
5911132 | Sloane | Jun 1999 | A |
5911687 | Sato et al. | Jun 1999 | A |
5912818 | McGrady et al. | Jun 1999 | A |
5913197 | Kameda | Jun 1999 | A |
5913310 | Brown | Jun 1999 | A |
5915089 | Stevens et al. | Jun 1999 | A |
5915240 | Karpf | Jun 1999 | A |
5919154 | Toavs et al. | Jul 1999 | A |
5921938 | Aoyama et al. | Jul 1999 | A |
5923018 | Kameda et al. | Jul 1999 | A |
5924074 | Evans | Jul 1999 | A |
5924103 | Ahmed et al. | Jul 1999 | A |
5927540 | Godlewski | Jul 1999 | A |
5931791 | Saltzstein et al. | Aug 1999 | A |
5935060 | Iliff | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5938413 | Makino et al. | Aug 1999 | A |
5939326 | Chupp et al. | Aug 1999 | A |
5939699 | Perttunen et al. | Aug 1999 | A |
5940306 | Gardner et al. | Aug 1999 | A |
5940802 | Hildebrand et al. | Aug 1999 | A |
5941829 | Saltzstein et al. | Aug 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5943423 | Muftic | Aug 1999 | A |
5943633 | Wilson et al. | Aug 1999 | A |
5944659 | Flach et al. | Aug 1999 | A |
5945651 | Chorosinski et al. | Aug 1999 | A |
5946083 | Melendez et al. | Aug 1999 | A |
5946659 | Lancelot et al. | Aug 1999 | A |
D414578 | Chen et al. | Sep 1999 | S |
5950006 | Crater et al. | Sep 1999 | A |
5951300 | Brown | Sep 1999 | A |
5951510 | Barak | Sep 1999 | A |
5954640 | Szabo | Sep 1999 | A |
5954885 | Bollish et al. | Sep 1999 | A |
5954971 | Pages et al. | Sep 1999 | A |
5956023 | Lyle et al. | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5959529 | Kail, IV | Sep 1999 | A |
5960085 | de la Huerga | Sep 1999 | A |
5960403 | Brown | Sep 1999 | A |
5960991 | Ophardt | Oct 1999 | A |
5961446 | Beller et al. | Oct 1999 | A |
5961448 | Swenson et al. | Oct 1999 | A |
5961487 | Davis | Oct 1999 | A |
5961923 | Nova et al. | Oct 1999 | A |
5963641 | Crandall et al. | Oct 1999 | A |
5964700 | Tallman et al. | Oct 1999 | A |
5966304 | Cook et al. | Oct 1999 | A |
5967975 | Ridgeway | Oct 1999 | A |
5970423 | Langley et al. | Oct 1999 | A |
5971593 | McGrady | Oct 1999 | A |
5971921 | Timbel | Oct 1999 | A |
5971948 | Pages et al. | Oct 1999 | A |
5974124 | Schlueter, Jr. et al. | Oct 1999 | A |
5975737 | Crater et al. | Nov 1999 | A |
5980490 | Tsoukalis | Nov 1999 | A |
5983193 | Heinonen et al. | Nov 1999 | A |
5987519 | Peifer et al. | Nov 1999 | A |
5991731 | Colon et al. | Nov 1999 | A |
5993046 | McGrady et al. | Nov 1999 | A |
5993420 | Hyman et al. | Nov 1999 | A |
5995077 | Wilcox et al. | Nov 1999 | A |
5995939 | Berman et al. | Nov 1999 | A |
5995965 | Experton | Nov 1999 | A |
5997167 | Crater et al. | Dec 1999 | A |
5997476 | Brown | Dec 1999 | A |
6003006 | Colella et al. | Dec 1999 | A |
6004020 | Bartur | Dec 1999 | A |
6004276 | Wright et al. | Dec 1999 | A |
6006191 | DeRienzo | Dec 1999 | A |
6006946 | Williams et al. | Dec 1999 | A |
6009333 | Chaco | Dec 1999 | A |
6010454 | Arieff et al. | Jan 2000 | A |
6011858 | Stock et al. | Jan 2000 | A |
6011999 | Holmes | Jan 2000 | A |
6012034 | Hamparian et al. | Jan 2000 | A |
6013057 | Danby et al. | Jan 2000 | A |
6014631 | Teagarden et al. | Jan 2000 | A |
6016444 | John | Jan 2000 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6018713 | Coli et al. | Jan 2000 | A |
6019745 | Gray | Feb 2000 | A |
6021392 | Lester et al. | Feb 2000 | A |
6022315 | Iliff | Feb 2000 | A |
6023522 | Draganoff et al. | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6027217 | McClure et al. | Feb 2000 | A |
6029138 | Khorasani et al. | Feb 2000 | A |
6032119 | Brown et al. | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6033076 | Braeuning et al. | Mar 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6039467 | Holmes | Mar 2000 | A |
6047259 | Campbell et al. | Apr 2000 | A |
6048086 | Valerino | Apr 2000 | A |
6050940 | Braun et al. | Apr 2000 | A |
6055487 | Margery et al. | Apr 2000 | A |
6057758 | Dempsey et al. | May 2000 | A |
6059736 | Tapper | May 2000 | A |
6061603 | Papadopoulos et al. | May 2000 | A |
6065819 | Holmes et al. | May 2000 | A |
6068153 | Young et al. | May 2000 | A |
6068156 | Liff et al. | May 2000 | A |
6073046 | Patel et al. | Jun 2000 | A |
6074345 | van Oostrom et al. | Jun 2000 | A |
6079621 | Vardanyan et al. | Jun 2000 | A |
6080106 | Lloyd et al. | Jun 2000 | A |
6081048 | Bergmann et al. | Jun 2000 | A |
6081786 | Barry et al. | Jun 2000 | A |
6082776 | Feinberg | Jul 2000 | A |
6083206 | Molko | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6095985 | Raymond et al. | Aug 2000 | A |
6096561 | Tayi | Aug 2000 | A |
6098892 | Peoples, Jr. | Aug 2000 | A |
6101407 | Groezinger | Aug 2000 | A |
6101478 | Brown | Aug 2000 | A |
6102856 | Groff et al. | Aug 2000 | A |
6108399 | Hernandez-Guerra et al. | Aug 2000 | A |
6108588 | McGrady | Aug 2000 | A |
6109774 | Holmes et al. | Aug 2000 | A |
6112224 | Peifer et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6113554 | Gilcher et al. | Sep 2000 | A |
6116461 | Broadfield et al. | Sep 2000 | A |
6117940 | Mjalli | Sep 2000 | A |
6123524 | Danby et al. | Sep 2000 | A |
6125350 | Dirbas | Sep 2000 | A |
6129517 | Danby et al. | Oct 2000 | A |
6132371 | Dempsey et al. | Oct 2000 | A |
6134504 | Douglas et al. | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6139177 | Venkatraman et al. | Oct 2000 | A |
6139495 | De La Huerga | Oct 2000 | A |
6141412 | Smith et al. | Oct 2000 | A |
6144922 | Douglas et al. | Nov 2000 | A |
6145695 | Garrigues | Nov 2000 | A |
6146523 | Kenley et al. | Nov 2000 | A |
6148297 | Swor et al. | Nov 2000 | A |
6149063 | Reynolds et al. | Nov 2000 | A |
6151536 | Arnold et al. | Nov 2000 | A |
6152364 | Schoonen et al. | Nov 2000 | A |
6154668 | Pedersen et al. | Nov 2000 | A |
6154726 | Rensimer et al. | Nov 2000 | A |
6157914 | Seto et al. | Dec 2000 | A |
6158965 | Butterfield et al. | Dec 2000 | A |
6160478 | Jacobsen et al. | Dec 2000 | A |
6161095 | Brown | Dec 2000 | A |
6161141 | Dillon | Dec 2000 | A |
6163737 | Fedor et al. | Dec 2000 | A |
6165154 | Gray et al. | Dec 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6170007 | Venkatraman et al. | Jan 2001 | B1 |
6170746 | Brook et al. | Jan 2001 | B1 |
6171112 | Clark et al. | Jan 2001 | B1 |
6171237 | Avitall et al. | Jan 2001 | B1 |
6171264 | Bader | Jan 2001 | B1 |
6173198 | Schulze et al. | Jan 2001 | B1 |
6175779 | Barrett | Jan 2001 | B1 |
6175977 | Schumacher et al. | Jan 2001 | B1 |
6176392 | William et al. | Jan 2001 | B1 |
6182047 | Dirbas | Jan 2001 | B1 |
6183417 | Geheb et al. | Feb 2001 | B1 |
6186145 | Brown | Feb 2001 | B1 |
6192320 | Margrey et al. | Feb 2001 | B1 |
6193480 | Butterfield | Feb 2001 | B1 |
6195887 | Danby et al. | Mar 2001 | B1 |
6198394 | Jacobsen et al. | Mar 2001 | B1 |
6200264 | Satherley et al. | Mar 2001 | B1 |
6200289 | Hochman et al. | Mar 2001 | B1 |
6202923 | Boyer et al. | Mar 2001 | B1 |
6203495 | Bardy | Mar 2001 | B1 |
6203528 | Deckert et al. | Mar 2001 | B1 |
6206238 | Ophardt | Mar 2001 | B1 |
6206829 | Iliff | Mar 2001 | B1 |
6210361 | Kamen et al. | Apr 2001 | B1 |
6213391 | Lewis | Apr 2001 | B1 |
6213738 | Danby et al. | Apr 2001 | B1 |
6213972 | Butterfield et al. | Apr 2001 | B1 |
6219439 | Burger | Apr 2001 | B1 |
6219587 | Ahlin et al. | Apr 2001 | B1 |
6221009 | Doi et al. | Apr 2001 | B1 |
6221011 | Bardy | Apr 2001 | B1 |
6221012 | Maschke et al. | Apr 2001 | B1 |
6222619 | Herron et al. | Apr 2001 | B1 |
6224549 | Drongelen | May 2001 | B1 |
6225901 | Kail, IV | May 2001 | B1 |
6226564 | Stuart | May 2001 | B1 |
6226745 | Wiederhold | May 2001 | B1 |
6230142 | Benigno et al. | May 2001 | B1 |
6230927 | Schoonen et al. | May 2001 | B1 |
6234997 | Kamen et al. | May 2001 | B1 |
6245013 | Minoz et al. | Jun 2001 | B1 |
6246473 | Smith, Jr. et al. | Jun 2001 | B1 |
6248063 | Barnhill et al. | Jun 2001 | B1 |
6248065 | Brown | Jun 2001 | B1 |
6255951 | De La Huerga | Jul 2001 | B1 |
6256643 | Cork et al. | Jul 2001 | B1 |
6256967 | Hebron et al. | Jul 2001 | B1 |
6259355 | Chaco et al. | Jul 2001 | B1 |
6259654 | De La Huerga | Jul 2001 | B1 |
6260021 | Wong et al. | Jul 2001 | B1 |
6266645 | Simpson | Jul 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
D446854 | Cheney, II et al. | Aug 2001 | S |
6270455 | Brown | Aug 2001 | B1 |
6270457 | Bardy | Aug 2001 | B1 |
6272394 | Lipps | Aug 2001 | B1 |
6272505 | De La Huerga | Aug 2001 | B1 |
6277072 | Bardy | Aug 2001 | B1 |
6278999 | Knapp | Aug 2001 | B1 |
6283322 | Liff et al. | Sep 2001 | B1 |
6283944 | McMullen et al. | Sep 2001 | B1 |
6290646 | Cosentino et al. | Sep 2001 | B1 |
6290650 | Butterfield et al. | Sep 2001 | B1 |
6294999 | Yarin et al. | Sep 2001 | B1 |
6295506 | Heinonen | Sep 2001 | B1 |
6304788 | Eady et al. | Oct 2001 | B1 |
6306088 | Krausman et al. | Oct 2001 | B1 |
6307956 | Black | Oct 2001 | B1 |
6308171 | De La Huerga | Oct 2001 | B1 |
6311163 | Sheehan et al. | Oct 2001 | B1 |
6312227 | Davis | Nov 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6314384 | Goetz | Nov 2001 | B1 |
6317719 | Schrier et al. | Nov 2001 | B1 |
6319200 | Lai et al. | Nov 2001 | B1 |
6321203 | Kameda | Nov 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6322504 | Kirshner | Nov 2001 | B1 |
6322515 | Goor et al. | Nov 2001 | B1 |
6330491 | Lion | Dec 2001 | B1 |
6332090 | DeFrank et al. | Dec 2001 | B1 |
RE37531 | Chaco et al. | Jan 2002 | E |
6337631 | Pai et al. | Jan 2002 | B1 |
6338007 | Broadfield et al. | Jan 2002 | B1 |
6339732 | Phoon et al. | Jan 2002 | B1 |
6345260 | Cummings, Jr. et al. | Feb 2002 | B1 |
6346886 | De La Huerga | Feb 2002 | B1 |
6347553 | Morris et al. | Feb 2002 | B1 |
6352200 | Schoonen et al. | Mar 2002 | B1 |
6353817 | Jacobs et al. | Mar 2002 | B1 |
6358225 | Butterfield | Mar 2002 | B1 |
6358237 | Paukovits et al. | Mar 2002 | B1 |
6361263 | Dewey et al. | Mar 2002 | B1 |
6362591 | Moberg | Mar 2002 | B1 |
6363282 | Nichols et al. | Mar 2002 | B1 |
6363290 | Lyle et al. | Mar 2002 | B1 |
6364834 | Reuss et al. | Apr 2002 | B1 |
6368273 | Brown | Apr 2002 | B1 |
6370841 | Chudy et al. | Apr 2002 | B1 |
6381577 | Brown | Apr 2002 | B1 |
6385505 | Lipps | May 2002 | B1 |
6393369 | Carr | May 2002 | B1 |
6397190 | Goetz | May 2002 | B1 |
6401072 | Haudenschild et al. | Jun 2002 | B1 |
6402702 | Gilcher et al. | Jun 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6407335 | Franklin-Lees et al. | Jun 2002 | B1 |
6408330 | DeLaHuerga | Jun 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6421650 | Goetz et al. | Jul 2002 | B1 |
6424996 | Killcommons et al. | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6434531 | Lancelot et al. | Aug 2002 | B1 |
6434569 | Tomlinson et al. | Aug 2002 | B1 |
6438451 | Lion | Aug 2002 | B1 |
RE37829 | Charhut et al. | Sep 2002 | E |
6449927 | Hebron et al. | Sep 2002 | B2 |
6450956 | Rappaport et al. | Sep 2002 | B1 |
6458102 | Mann et al. | Oct 2002 | B1 |
6461037 | O'Leary | Oct 2002 | B1 |
6463310 | Swedlow et al. | Oct 2002 | B1 |
6468242 | Wilson et al. | Oct 2002 | B1 |
6470234 | McGrady | Oct 2002 | B1 |
6471089 | Liff et al. | Oct 2002 | B2 |
6471645 | Warkentin et al. | Oct 2002 | B1 |
6471646 | Thede | Oct 2002 | B1 |
6475146 | Frelburger et al. | Nov 2002 | B1 |
6475148 | Jackson et al. | Nov 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6478737 | Bardy | Nov 2002 | B2 |
6485465 | Moberg et al. | Nov 2002 | B2 |
6494831 | Koritzinsky | Dec 2002 | B1 |
6511138 | Gardner et al. | Jan 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6537244 | Paukovits | Mar 2003 | B2 |
6542902 | Dulong et al. | Apr 2003 | B2 |
6542910 | Cork et al. | Apr 2003 | B2 |
6544174 | West et al. | Apr 2003 | B2 |
6544228 | Heitmeier | Apr 2003 | B1 |
6551243 | Bocionek et al. | Apr 2003 | B2 |
6551276 | Mann et al. | Apr 2003 | B1 |
6554791 | Cartledge et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6555986 | Moberg | Apr 2003 | B2 |
6558321 | Burd et al. | May 2003 | B1 |
6561975 | Pool et al. | May 2003 | B1 |
6562001 | Lebel et al. | May 2003 | B2 |
6564104 | Nelson et al. | May 2003 | B2 |
6564105 | Starkweather et al. | May 2003 | B2 |
6564121 | Wallace et al. | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6575900 | Zweig et al. | Jun 2003 | B1 |
6577899 | Lebel et al. | Jun 2003 | B2 |
6579232 | Sakamaki et al. | Jun 2003 | B2 |
6581069 | Robinson et al. | Jun 2003 | B1 |
6581798 | Liff et al. | Jun 2003 | B2 |
6584336 | Ali et al. | Jun 2003 | B1 |
6585157 | Brandt et al. | Jul 2003 | B2 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6585675 | O'Mahony et al. | Jul 2003 | B1 |
6592551 | Cobb | Jul 2003 | B1 |
6593528 | Franklin-Lees et al. | Jul 2003 | B2 |
6602469 | Maus et al. | Aug 2003 | B1 |
6607485 | Bardy | Aug 2003 | B2 |
6610973 | Davis, III | Aug 2003 | B1 |
6613009 | Bainbridge et al. | Sep 2003 | B1 |
6616633 | Butterfield et al. | Sep 2003 | B1 |
6635014 | Starkweather et al. | Oct 2003 | B2 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6659948 | Lebel et al. | Dec 2003 | B2 |
6664893 | Eveland et al. | Dec 2003 | B1 |
6668196 | Villegas et al. | Dec 2003 | B1 |
6669663 | Thompson | Dec 2003 | B1 |
6673314 | Burbank et al. | Jan 2004 | B1 |
6687546 | Lebel et al. | Jan 2004 | B2 |
6689091 | Bui et al. | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6694334 | DuLong et al. | Feb 2004 | B2 |
6711460 | Reese | Mar 2004 | B1 |
6731324 | Levy | May 2004 | B2 |
6733447 | Lai et al. | May 2004 | B2 |
6735497 | Wallace et al. | May 2004 | B2 |
6740075 | Lebel et al. | May 2004 | B2 |
6746398 | Hervy et al. | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6771369 | Rzasa et al. | Aug 2004 | B2 |
6775602 | Gordon, Jr. et al. | Aug 2004 | B2 |
6776304 | Liff et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6804656 | Rosenfeld et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6811533 | Lebel et al. | Nov 2004 | B2 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6811707 | Rovatti et al. | Nov 2004 | B2 |
6813473 | Bruker | Nov 2004 | B1 |
6813519 | Lebel et al. | Nov 2004 | B2 |
6814255 | Liff et al. | Nov 2004 | B2 |
6820093 | De La Huerga | Nov 2004 | B2 |
6842736 | Brzozowski | Jan 2005 | B1 |
6847861 | Lunak et al. | Jan 2005 | B2 |
6854088 | Massengale et al. | Feb 2005 | B2 |
6871211 | Labounty et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6877530 | Osborne et al. | Apr 2005 | B2 |
6880034 | Manke et al. | Apr 2005 | B2 |
6885288 | Pincus | Apr 2005 | B2 |
6887201 | Bardy | May 2005 | B2 |
6892941 | Rosenblum | May 2005 | B2 |
6912549 | Rotter et al. | Jun 2005 | B2 |
6913590 | Sorenson et al. | Jul 2005 | B2 |
6915265 | Johnson | Jul 2005 | B1 |
6915823 | Osborne et al. | Jul 2005 | B2 |
6928452 | De La Huerga | Aug 2005 | B2 |
6950708 | Bowman, IV et al. | Sep 2005 | B2 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6975924 | Kircher et al. | Dec 2005 | B2 |
6976628 | Krupa | Dec 2005 | B2 |
6979306 | Moll | Dec 2005 | B2 |
6980958 | Surwit et al. | Dec 2005 | B1 |
6981644 | Cheong et al. | Jan 2006 | B2 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6991002 | Osborne et al. | Jan 2006 | B2 |
6995664 | Darling | Feb 2006 | B1 |
7006893 | Hart et al. | Feb 2006 | B2 |
7015806 | Naidoo et al. | Mar 2006 | B2 |
7017622 | Osborne et al. | Mar 2006 | B2 |
7017623 | Tribble et al. | Mar 2006 | B2 |
7028723 | Alouani et al. | Apr 2006 | B1 |
7096212 | Tribble et al. | Aug 2006 | B2 |
7117902 | Osborne | Oct 2006 | B2 |
7151982 | Liff et al. | Dec 2006 | B2 |
7194336 | DiGianfilippo et al. | Mar 2007 | B2 |
7209891 | Addy et al. | Apr 2007 | B1 |
7240699 | Osborne et al. | Jul 2007 | B2 |
7255680 | Gharib | Aug 2007 | B1 |
7277579 | Huang | Oct 2007 | B2 |
7277757 | Casavant et al. | Oct 2007 | B2 |
7317967 | DiGianfilippo et al. | Jan 2008 | B2 |
7321861 | Oon | Jan 2008 | B1 |
7343224 | DiGianfilippo et al. | Mar 2008 | B2 |
7403901 | Carley et al. | Jul 2008 | B1 |
7427002 | Liff et al. | Sep 2008 | B2 |
7493263 | Helmus et al. | Feb 2009 | B2 |
7499581 | Tribble | Mar 2009 | B2 |
7509280 | Haudenschild | Mar 2009 | B1 |
7555557 | Bradley et al. | Jun 2009 | B2 |
7561312 | Proudfoot et al. | Jul 2009 | B1 |
7581953 | Lehmann et al. | Sep 2009 | B2 |
7599516 | Limer | Oct 2009 | B2 |
7610115 | Rob et al. | Oct 2009 | B2 |
7630908 | Amrien et al. | Dec 2009 | B1 |
7636718 | Steen et al. | Dec 2009 | B1 |
7672859 | Louie et al. | Mar 2010 | B1 |
7698019 | Moncrief et al. | Apr 2010 | B2 |
7698154 | Marchosky | Apr 2010 | B2 |
7734478 | Goodall et al. | Jun 2010 | B2 |
7753085 | Tribble et al. | Jul 2010 | B2 |
7769601 | Bleser et al. | Aug 2010 | B1 |
7783383 | Eliuk et al. | Aug 2010 | B2 |
D624225 | Federico et al. | Sep 2010 | S |
7801642 | Ansari et al. | Sep 2010 | B2 |
7847970 | McGrady | Dec 2010 | B1 |
7853621 | Guo | Dec 2010 | B2 |
7904822 | Monteleone et al. | Mar 2011 | B2 |
7931859 | Mlodzinski et al. | Apr 2011 | B2 |
7937290 | Bahir | May 2011 | B2 |
7986369 | Burns | Jul 2011 | B1 |
7991507 | Liff et al. | Aug 2011 | B2 |
8170271 | Chen | May 2012 | B2 |
8191339 | Tribble | Jun 2012 | B2 |
8215557 | Reno et al. | Jul 2012 | B1 |
8220503 | Tribble | Jul 2012 | B2 |
8225824 | Eliuk et al. | Jul 2012 | B2 |
D667961 | Marmier | Sep 2012 | S |
8267129 | Doherty et al. | Sep 2012 | B2 |
8271138 | Eliuk et al. | Sep 2012 | B2 |
8280549 | Liff et al. | Oct 2012 | B2 |
8284305 | Newcomb et al. | Oct 2012 | B2 |
8374887 | Alexander | Feb 2013 | B1 |
8386070 | Eliuk et al. | Feb 2013 | B2 |
8548824 | daCosta | Oct 2013 | B1 |
8554579 | Tribble et al. | Oct 2013 | B2 |
D693480 | Spiess et al. | Nov 2013 | S |
8595206 | Ansari | Nov 2013 | B1 |
8666541 | Ansari et al. | Mar 2014 | B1 |
8678047 | Tribble et al. | Mar 2014 | B2 |
D715958 | Bossart et al. | Oct 2014 | S |
9053218 | Osborne et al. | Jun 2015 | B2 |
D733480 | Shao | Jul 2015 | S |
D738152 | Grasselli et al. | Sep 2015 | S |
D753428 | Shao | Apr 2016 | S |
9362969 | Burgess et al. | Jun 2016 | B1 |
9382021 | Tribble et al. | Jul 2016 | B2 |
9662273 | Ranalletta et al. | May 2017 | B2 |
9930297 | Alexander et al. | Mar 2018 | B2 |
9956145 | Thompson et al. | May 2018 | B2 |
20010001237 | Stroda et al. | May 2001 | A1 |
20010003177 | Schena et al. | Jun 2001 | A1 |
20010007053 | Bardy | Jul 2001 | A1 |
20010007932 | Kamen et al. | Jul 2001 | A1 |
20010011153 | Bardy | Aug 2001 | A1 |
20010016699 | Burbank et al. | Aug 2001 | A1 |
20010017817 | De La Huerga | Aug 2001 | A1 |
20010021801 | Bardy | Sep 2001 | A1 |
20010025138 | Bardy | Sep 2001 | A1 |
20010025156 | Bui et al. | Sep 2001 | A1 |
20010027634 | Hebron et al. | Oct 2001 | A1 |
20010028308 | De La Huerga | Oct 2001 | A1 |
20010030234 | Wiklof | Oct 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010032101 | Statius Muller | Oct 2001 | A1 |
20010034502 | Moberg et al. | Oct 2001 | A1 |
20010034614 | Fletcher-Haynes et al. | Oct 2001 | A1 |
20010034616 | Giannini | Oct 2001 | A1 |
20010037057 | Bardy | Nov 2001 | A1 |
20010037083 | Hartlaub et al. | Nov 2001 | A1 |
20010037217 | Abensour et al. | Nov 2001 | A1 |
20010037220 | Merry et al. | Nov 2001 | A1 |
20010041920 | Starkweather et al. | Nov 2001 | A1 |
20010044588 | Mault | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20010047125 | Quy | Nov 2001 | A1 |
20010051764 | Bardy | Dec 2001 | A1 |
20010053885 | Gielen et al. | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002473 | Schrier et al. | Jan 2002 | A1 |
20020004645 | Carlisle et al. | Jan 2002 | A1 |
20020007285 | Rappaport | Jan 2002 | A1 |
20020010568 | Rubbert et al. | Jan 2002 | A1 |
20020010679 | Felsher | Jan 2002 | A1 |
20020013612 | Whitehurst | Jan 2002 | A1 |
20020016567 | Hochman et al. | Feb 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020016719 | Nemeth et al. | Feb 2002 | A1 |
20020016722 | Kameda | Feb 2002 | A1 |
20020019606 | Lebel et al. | Feb 2002 | A1 |
20020019748 | Brown | Feb 2002 | A1 |
20020022776 | Bardy | Feb 2002 | A1 |
20020025796 | Taylor et al. | Feb 2002 | A1 |
20020026104 | Bardy | Feb 2002 | A1 |
20020029157 | Marchosky | Mar 2002 | A1 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020032582 | Feeney et al. | Mar 2002 | A1 |
20020032602 | Lanzillo, Jr. et al. | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020044043 | Chaco et al. | Apr 2002 | A1 |
20020046062 | Kameda | Apr 2002 | A1 |
20020046185 | Villart et al. | Apr 2002 | A1 |
20020046346 | Evans | Apr 2002 | A1 |
20020052539 | Haller et al. | May 2002 | A1 |
20020052542 | Bardy | May 2002 | A1 |
20020052574 | Hochman et al. | May 2002 | A1 |
20020062227 | Yuyama | May 2002 | A1 |
20020062229 | Alban et al. | May 2002 | A1 |
20020065540 | Lebel et al. | May 2002 | A1 |
20020065686 | Monteleone et al. | May 2002 | A1 |
20020067273 | Jaques et al. | Jun 2002 | A1 |
20020072733 | Flaherty | Jun 2002 | A1 |
20020073250 | Ommering | Jun 2002 | A1 |
20020077852 | Ford et al. | Jun 2002 | A1 |
20020077865 | Sullivan | Jun 2002 | A1 |
20020082480 | Riff et al. | Jun 2002 | A1 |
20020082865 | Bianco et al. | Jun 2002 | A1 |
20020082868 | Pories et al. | Jun 2002 | A1 |
20020084904 | De La Huerga | Jul 2002 | A1 |
20020087120 | Rogers et al. | Jul 2002 | A1 |
20020091309 | Auer | Jul 2002 | A1 |
20020099283 | Christ et al. | Jul 2002 | A1 |
20020099301 | Bardy | Jul 2002 | A1 |
20020100762 | Liff et al. | Aug 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020107707 | Naparstek et al. | Aug 2002 | A1 |
20020116226 | Auer et al. | Aug 2002 | A1 |
20020116509 | De La Huerga | Aug 2002 | A1 |
20020128606 | Cowan et al. | Sep 2002 | A1 |
20020128871 | Adamson et al. | Sep 2002 | A1 |
20020128880 | Kunikiyo | Sep 2002 | A1 |
20020133377 | Brown | Sep 2002 | A1 |
20020140675 | Ali et al. | Oct 2002 | A1 |
20020143254 | Maruyama | Oct 2002 | A1 |
20020156462 | Stultz | Oct 2002 | A1 |
20020158128 | Ashiuro | Oct 2002 | A1 |
20020165491 | Reilly | Nov 2002 | A1 |
20020169636 | Eggers et al. | Nov 2002 | A1 |
20020173875 | Wallace et al. | Nov 2002 | A1 |
20020188467 | Eke | Dec 2002 | A1 |
20020198473 | Kumar et al. | Dec 2002 | A1 |
20020198513 | Lebel et al. | Dec 2002 | A1 |
20020198624 | Greenwald | Dec 2002 | A1 |
20030006878 | Chung | Jan 2003 | A1 |
20030023177 | Bardy | Jan 2003 | A1 |
20030033532 | Marks | Feb 2003 | A1 |
20030036783 | Bauhahn et al. | Feb 2003 | A1 |
20030046114 | Davies et al. | Mar 2003 | A1 |
20030046280 | Rotter et al. | Mar 2003 | A1 |
20030046439 | Manke et al. | Mar 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030050731 | Rosenblum | Mar 2003 | A1 |
20030052787 | Zerhusen | Mar 2003 | A1 |
20030060753 | Starkweather et al. | Mar 2003 | A1 |
20030060754 | Reilly | Mar 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030060768 | Kiyatake | Mar 2003 | A1 |
20030065287 | Spohn et al. | Apr 2003 | A1 |
20030076736 | Buker et al. | Apr 2003 | A1 |
20030078534 | Hochman et al. | Apr 2003 | A1 |
20030079746 | Hickle | May 2003 | A1 |
20030083901 | Bosch et al. | May 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030097092 | Flaherty | May 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030117580 | Franz et al. | Jun 2003 | A1 |
20030125609 | Becker | Jul 2003 | A1 |
20030125611 | Bardy | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030144878 | Wilkes et al. | Jul 2003 | A1 |
20030149599 | Goodall et al. | Aug 2003 | A1 |
20030154108 | Fletcher-Haynes et al. | Aug 2003 | A1 |
20030158508 | DiGianfilippo | Aug 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030163789 | Blomquist | Aug 2003 | A1 |
20030167035 | Flaherty et al. | Sep 2003 | A1 |
20030176933 | Lebel et al. | Sep 2003 | A1 |
20030179287 | Kozic et al. | Sep 2003 | A1 |
20030181851 | Mann et al. | Sep 2003 | A1 |
20030182164 | Blomquist | Sep 2003 | A1 |
20030195397 | Bardy | Oct 2003 | A1 |
20030200117 | Manetta et al. | Oct 2003 | A1 |
20030201697 | Richardson | Oct 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030225596 | Richardson et al. | Dec 2003 | A1 |
20030225728 | Moura | Dec 2003 | A1 |
20030231803 | Huang | Dec 2003 | A1 |
20040002874 | Shaffer et al. | Jan 2004 | A1 |
20040017475 | Akers et al. | Jan 2004 | A1 |
20040019607 | Moubayed et al. | Jan 2004 | A1 |
20040115132 | Brown | Jan 2004 | A1 |
20040039260 | Bardy | Feb 2004 | A1 |
20040039264 | Bardy | Feb 2004 | A1 |
20040051368 | Caputo et al. | Mar 2004 | A1 |
20040055611 | Penny et al. | Mar 2004 | A1 |
20040064343 | Korpman et al. | Apr 2004 | A1 |
20040073329 | Engleson | Apr 2004 | A1 |
20040088187 | Chudy et al. | May 2004 | A1 |
20040088374 | Webb et al. | May 2004 | A1 |
20040111293 | Firanek et al. | Jun 2004 | A1 |
20040116862 | Ray | Jun 2004 | A1 |
20040117215 | Marchosky | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040129616 | Mori et al. | Jul 2004 | A1 |
20040148195 | Kalies | Jul 2004 | A1 |
20040158193 | Bui et al. | Aug 2004 | A1 |
20040172283 | Vanderveen et al. | Sep 2004 | A1 |
20040172289 | Kozic et al. | Sep 2004 | A1 |
20040172300 | Mihai et al. | Sep 2004 | A1 |
20040193328 | Zaitsu et al. | Sep 2004 | A1 |
20040193453 | Butterfield et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040204954 | Lacko | Oct 2004 | A1 |
20040215490 | Duchon et al. | Oct 2004 | A1 |
20040220829 | Baharav et al. | Nov 2004 | A1 |
20040225528 | Brock | Nov 2004 | A1 |
20040235446 | Flaherty et al. | Nov 2004 | A1 |
20040236630 | Kost et al. | Nov 2004 | A1 |
20040248295 | Katsuhiko et al. | Dec 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20040260577 | Dahlin et al. | Dec 2004 | A1 |
20050001033 | Cheong et al. | Jan 2005 | A1 |
20050017864 | Tsoukalis | Jan 2005 | A1 |
20050033124 | Kelly et al. | Feb 2005 | A1 |
20050033773 | Roberge et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050039742 | Hickle | Feb 2005 | A1 |
20050043665 | Vinci et al. | Feb 2005 | A1 |
20050045548 | Brugger et al. | Mar 2005 | A1 |
20050054923 | Pan | Mar 2005 | A1 |
20050060372 | DeBettencourt et al. | Mar 2005 | A1 |
20050080651 | Morrison et al. | Apr 2005 | A1 |
20050187794 | Kimak | Aug 2005 | A1 |
20050209737 | Kircher | Sep 2005 | A1 |
20050228238 | Monitzer | Oct 2005 | A1 |
20050279419 | Tribble et al. | Dec 2005 | A1 |
20060084042 | Weaver et al. | Apr 2006 | A1 |
20060124656 | Popovich, Jr. | Jun 2006 | A1 |
20060136095 | Rob et al. | Jun 2006 | A1 |
20060149416 | Mohapatra et al. | Jul 2006 | A1 |
20060161294 | DiMaggio | Jul 2006 | A1 |
20060173714 | Grotzinger, Jr. | Aug 2006 | A1 |
20060178578 | Tribble et al. | Aug 2006 | A1 |
20060181391 | McNeill et al. | Aug 2006 | A1 |
20060235881 | Masarie et al. | Oct 2006 | A1 |
20060259195 | Eliuk | Nov 2006 | A1 |
20070043767 | Osborne et al. | Feb 2007 | A1 |
20070047980 | Limer et al. | Mar 2007 | A1 |
20070088568 | Goodall et al. | Apr 2007 | A1 |
20070110305 | Corcoran et al. | May 2007 | A1 |
20070125442 | Tribble et al. | Jun 2007 | A1 |
20070168228 | Lawless | Jul 2007 | A1 |
20070179806 | Knowlton et al. | Aug 2007 | A1 |
20070189597 | Limer et al. | Aug 2007 | A1 |
20070192139 | Cookson et al. | Aug 2007 | A1 |
20070216998 | Sander | Sep 2007 | A1 |
20070239482 | Finn et al. | Oct 2007 | A1 |
20070239997 | Qu et al. | Oct 2007 | A1 |
20080046292 | Myers et al. | Feb 2008 | A1 |
20080056556 | Eller et al. | Mar 2008 | A1 |
20080059228 | Bossi et al. | Mar 2008 | A1 |
20080091467 | Moncrief et al. | Apr 2008 | A1 |
20080119958 | Bear et al. | May 2008 | A1 |
20080125897 | DiGianfilippo et al. | May 2008 | A1 |
20080147554 | Stevens et al. | Jun 2008 | A1 |
20080195246 | Tribble et al. | Aug 2008 | A1 |
20080306926 | Friedlander et al. | Dec 2008 | A1 |
20090024414 | Mansour et al. | Jan 2009 | A1 |
20090080408 | Natoli et al. | Mar 2009 | A1 |
20090097368 | Vlutters et al. | Apr 2009 | A1 |
20090138340 | Borr et al. | May 2009 | A1 |
20090188937 | Kim | Jul 2009 | A1 |
20090205877 | Claypool | Aug 2009 | A1 |
20090210252 | Silver | Aug 2009 | A1 |
20090235194 | Arndt et al. | Sep 2009 | A1 |
20090258331 | Do et al. | Oct 2009 | A1 |
20090285762 | Flower | Nov 2009 | A1 |
20090313044 | Haque et al. | Dec 2009 | A1 |
20090323170 | Lin | Dec 2009 | A1 |
20090324032 | Chen | Dec 2009 | A1 |
20100017031 | Rob et al. | Jan 2010 | A1 |
20100091281 | Suzuki | Apr 2010 | A1 |
20100094653 | Tribble | Apr 2010 | A1 |
20100128165 | Newcomb et al. | May 2010 | A1 |
20100157293 | Rzasa et al. | Jun 2010 | A9 |
20100185456 | Kansal | Jul 2010 | A1 |
20100241270 | Eliuk et al. | Sep 2010 | A1 |
20110119088 | Gunn | May 2011 | A1 |
20110191121 | Fioravanti | Aug 2011 | A1 |
20110202366 | Akers et al. | Aug 2011 | A1 |
20110208350 | Eliuk et al. | Aug 2011 | A1 |
20110267465 | Alexander et al. | Nov 2011 | A1 |
20120083666 | Waugh | Apr 2012 | A1 |
20120097290 | Mikhaeil | Apr 2012 | A1 |
20120200596 | Gotou et al. | Aug 2012 | A1 |
20120211565 | Colavito et al. | Aug 2012 | A1 |
20120241043 | Perazzo | Sep 2012 | A1 |
20120303388 | Suresh-Kumar Benkata Vishnubhalta et al. | Nov 2012 | A1 |
20130079581 | Agamaite | Mar 2013 | A1 |
20130090947 | Nockley | Apr 2013 | A1 |
20130197445 | Schabbach | Aug 2013 | A1 |
20130262138 | Jaskela et al. | Oct 2013 | A1 |
20130279774 | Helgason et al. | Oct 2013 | A1 |
20130304510 | Chan et al. | Nov 2013 | A1 |
20130314535 | Yuyama et al. | Nov 2013 | A1 |
20130342676 | Amano | Dec 2013 | A1 |
20140022569 | Matsui et al. | Jan 2014 | A1 |
20140156064 | Crawford et al. | Jun 2014 | A1 |
20140156294 | Tribble et al. | Jun 2014 | A1 |
20140214436 | Utech et al. | Jul 2014 | A1 |
20140350950 | Jaskela et al. | Nov 2014 | A1 |
20150205932 | Tribble | Jul 2015 | A1 |
20150227719 | Ranalletta | Aug 2015 | A1 |
20150272320 | Ranalletta et al. | Oct 2015 | A1 |
20150278477 | Tribble | Oct 2015 | A1 |
20150286799 | Padmani | Oct 2015 | A1 |
20160072985 | Sandmann et al. | Mar 2016 | A1 |
20160092638 | Padmani | Mar 2016 | A1 |
20160092639 | Padmani | Mar 2016 | A1 |
20160140315 | Diaz et al. | May 2016 | A1 |
20160210437 | Padmani et al. | Jul 2016 | A1 |
20160371462 | Wallen | Dec 2016 | A1 |
20170372034 | Tribble | Dec 2017 | A1 |
Number | Date | Country |
---|---|---|
1516257 | May 1999 | CN |
2440518 | Aug 2001 | CN |
1131076 | Dec 2003 | CN |
0237588 | Sep 1987 | EP |
0462466 | Dec 1991 | EP |
0505627 | Sep 1992 | EP |
0522527 | Jan 1993 | EP |
0439355 | Sep 1994 | EP |
0844581 | May 1998 | EP |
0960627 | Dec 1999 | EP |
0970655 | Jan 2000 | EP |
1072994 | Feb 2001 | EP |
1107158 | Jun 2001 | EP |
1097671 | Feb 2003 | EP |
994977 | Jun 1965 | GB |
2210713 | Feb 1987 | GB |
2279784 | Jan 1995 | GB |
2285135 | Jun 1995 | GB |
2379037 | Feb 2003 | GB |
53137644 | Dec 1978 | JP |
61066950 | Apr 1986 | JP |
63068133 | Mar 1988 | JP |
2111375 | Apr 1990 | JP |
3423055 | Jan 1994 | JP |
6086813 | Mar 1994 | JP |
06327636 | Nov 1994 | JP |
07204253 | Aug 1995 | JP |
104585 | Jan 1998 | JP |
10014890 | Jan 1998 | JP |
10079770 | Mar 1998 | JP |
2000036032 | Feb 2000 | JP |
03055131 | Apr 2000 | JP |
2002011095 | Jan 2002 | JP |
2002092181 | Mar 2002 | JP |
2002520718 | Jul 2002 | JP |
2003022322 | Jan 2003 | JP |
2004078970 | Mar 2004 | JP |
2004326436 | Nov 2004 | JP |
2004340770 | Dec 2004 | JP |
2005252710 | Sep 2005 | JP |
2006033291 | Feb 2006 | JP |
2006334062 | Dec 2006 | JP |
2007198934 | Aug 2007 | JP |
2008139201 | Jun 2008 | JP |
4276654 | Jun 2009 | JP |
2009265827 | Nov 2009 | JP |
2010056619 | Mar 2010 | JP |
2010170504 | Aug 2010 | JP |
2010533927 | Oct 2010 | JP |
2011151430 | Aug 2011 | JP |
2012078265 | Apr 2012 | JP |
5342197 | Nov 2013 | JP |
5747150 | Jul 2015 | JP |
6086813 | Mar 2017 | JP |
20000036642 | Jul 2000 | KR |
1020000036642 | Jul 2000 | KR |
20010094703 | Nov 2001 | KR |
1020010094703 | Nov 2001 | KR |
20050054379 | Dec 2003 | KR |
20110115927 | Oct 2011 | KR |
1020110115927 | Oct 2011 | KR |
20130001500 | Jan 2013 | KR |
WO8400493 | Feb 1984 | WO |
WO9524010 | Sep 1995 | WO |
WO9634291 | Oct 1996 | WO |
WO9741525 | Nov 1997 | WO |
WO9814275 | Apr 1998 | WO |
WO9815092 | Apr 1998 | WO |
WO9824358 | Jun 1998 | WO |
WO9833433 | Aug 1998 | WO |
WO9859487 | Dec 1998 | WO |
WO9904043 | Jan 1999 | WO |
WO9910029 | Mar 1999 | WO |
WO9942933 | Aug 1999 | WO |
WO9944162 | Sep 1999 | WO |
WO9959472 | Nov 1999 | WO |
WO0013588 | Mar 2000 | WO |
WO0029983 | May 2000 | WO |
WO0043941 | Jul 2000 | WO |
WO0052437 | Sep 2000 | WO |
WO0052626 | Sep 2000 | WO |
WO0057339 | Sep 2000 | WO |
WO0060449 | Oct 2000 | WO |
WO0069331 | Nov 2000 | WO |
WO0072181 | Nov 2000 | WO |
WO0078374 | Dec 2000 | WO |
WO0101305 | Jan 2001 | WO |
WO0102979 | Jan 2001 | WO |
WO0106468 | Jan 2001 | WO |
WO0145774 | Jun 2001 | WO |
WO0217777 | Jul 2002 | WO |
WO02091276 | Nov 2002 | WO |
WO03025826 | Mar 2003 | WO |
WO03094073 | Nov 2003 | WO |
WO2004070557 | Aug 2004 | WO |
WO2004070994 | Aug 2004 | WO |
Entry |
---|
AHRQ Health Information Technology Program—Update Jun. 2005 Fact Sheet,, http://www.ahrq.gov/research/findings/factsheets/it/hitfact/index.html—3 pages. |
Albert A. Cook, “An integrated nursing-pharmacy approach to a computerized medication dispensing/administration system,” Hospital Pharmacy, May 1985, pp. 321-325, vol. 20, JB Lippincott Company, Philadelphia, PA. |
Allan T. Pryor, “Current State of Computer-based Patient Record Systems,” Aspects of the Computer-based Patient Record, 1992, pp. 67-82, Springer-Verlag, New York, NY. |
Anderson, Howard “A Narrative on the History of the Development of Telepharmacy in North Dakota from the Board of Pharmacy's Perspective Recorded by Excerpts from Board Minutes”, Feb. 2006. |
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999, pp. 1404-1405. |
Ann Slone Endo, “Using Computers in Newborn Intensive Care Settings,” American Journal of Nursing, Jul. 1981, pp. 1336-1337. |
Anonymous, “Chains covet customized pharmacy integration” Drug Store New, Aug. 18, 2003, vol. 25, No. 10—p. 73. |
Automated Dispensing Technologies: Directory of Vendors, http://pharmacyautomation.com/vendors.html, Jun. 5, 2003—3 pages. |
Auto Syringe® AS40A Infusion Pump Technical Manual, 1995, 89 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Auto Syringe® AS40A: Model AS40A Infusion Pump Operation Manual, undated, 78 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Baxa Corporation, DoseEdge The Leading Edge in Dose Management, Brochure, published copyright date 2010—5 pages. |
Baxa Corporation, Product Catalog 2010-2011, published at least by Sep. 15, 2012, https://web.archive.org/web/20120915210739http://www.baxa.com/resources/docs/BaxaCatalog.pdf (52 pages). |
Bell Atlantic Healthcare Systems, Inc., court exhibit, StatLan Functions and Features, Specification, release 3.5, dated Nov. 12, 1992, 49 pages. |
Ben Schneiderman, “Designing the User Interface: Strategies for Effective Human-Computer Interaction,” 2d Ed., 1992, Chapter 5: Direct Manipulation (56 pages), Addison-Wesley Publishing Company. |
“Block Medical: Growing with Home Infusion Therapy,” taken from Invivo, The Business and Medicine Report, Apr. 1991, pp. 7-9. |
Bynum et al., “The Effect of Telepharmacy Counseling on Metered-Dose Inhaler Technique among Adolescents with Asthma in Rural Arkansas”, Telemedicine Journal and e-health, vol. 7, No. 3, 2001, Mary AnnLiebert, Inc., pp. 207-218. |
Cabral, Jr. et al., “Multmedia Systems for Telemedicine Systems for Telemedicine and Their Communications Requirements,” IEEE Communications Magazine Jul. 1996, pp. 20-27. |
Cardinal Health Introduces Rxe-source(SM) to Address Pharmacist Labor Shortage and Medication Safety Challenges at Hospitals. PR Newswire, Feb. 25, 2003—5 pages. |
Casey, Michelle M. et al., “Pharmacist Staffing and the Use of Technology in Small Rural Hospitals: Implications for Medication Safety” Upper Midwest Rural Health Research Center, Dec. 2005—51 pages. |
Cato Reference Manual, Support for Trial Version (Abridged), Vienna, May 2004 Jun. 1, 2004. |
Cato Reference Manual, Vienna, May 2005 May 1, 2005. |
Charles Safran, M.D. et al., “Computer-Based Support for Clinical Decision Making,” Clinical Computin, vol. 7, No. 5 (1990), pp. 319-322. |
Clayton M. Curtis, “A Computer-based Patient Record Emerging from the Public Sector: The Decentralized Hospital Computer Program,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 75-132, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Clement J. McDonald, M.D. et al, “The Three-Legged Stool: Regenstrief Institute for Health Care,” Third Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1997, pp. 131-158, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Clement J. McDonald, M.D. et al., The Regenstrief Medical Record System: 20 Years of Experience in Hospitals, Clinics, and Neighborhood Health Centers,: M.D. Computing, 1992 pp. 206-217, vol. 9, No. 4, Springer-Verlag, New York, NY. |
Clifton, G. Dennis et al., “Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing” Am J Health-Syst Pharm, vol. 60, Dec. 15, 2003 oe pp. 2577-2582. |
Dan Murphy, “Nuclear Pharmacy Primer”, Radiation Protection Management, vol. 20, No. 5 (2003), pp. 1-10. |
Dan Scheraga; “Tech firms answer chain pharmacy's call for productivity,” Drug Store News; Dec. 15, 2003; 25, 17; ProQuest Research Library, p. 31-32. |
Daniel Andresen et al., “Scalability Issues for High Performance Digital Libraries on the World Wide Web,” Proceedings of ADL '96, 1996, pp. 139-148, IEEE. |
Daniel J. Nigrin et al., “Glucoweb: A Case Study of Secure, Remote Biomonitoring and Communication,” Proceedings of the 2000, 5 pages, American Medical Informatics Association, Bethesda, MD. |
Darryl V. Wareham et al., “Combination Medication Cart and Computer Terminal in Decentralized Drug Distribution,” American Journal of Hospital Pharmacy, Jun. 1983, pp. 976-978, vol. 40, American Society of Hospital Pharmacists. |
Dart, Luann, “Digital Doses” Rural Electric, Jan. 2005—pp. 28-31. |
Deborah J. Mayhew, “Principles and Guidelines in Software user Interface Designs,” 1992, selected portions of Chapter 9, 17 pages, Prentice-Hall, Inc. |
Defendants Initial Invalidity Contentions with Exhibits A and B dated Sep. 8, 2014; Civil Action No. 1:14-cv-00222. |
Dennis D. Cote et al., “Robotic system for i.v. antineoplastic drug preparation: Description and preliminary evaluation under simulated conditions,” American Journal of Hospital Pharmacy, Nov. 1989, pp. 2286-2293, vol. 46, American Society of Hospital Pharmacists. |
Donna Young; “Loan repayments help pharmacists provide care in medically underserved areas,” American Journal of Health-System Pharmacy; Nov. 1, 2003, pp. 2186-2188, vol. 60. |
Environmental Scan of Pharmacy Technicians; M. MacInnis; Canadian Pharmacists Association; Sep. 2001. |
Exhibit 1, Publications Manually Reviewed for the Search to U.S. Pat. No. 8,347,887 titled “System and Method for Remotely Supervising and Verifying Pharmacy Functions” As of Jun. 25, 2014. |
Exhibit 1001 U.S. Pat. No. 8,374,887, Alexander issued Feb. 12, 2013. |
Exhibit 1002 Patent File History U.S. Pat. No. 8,374,887. |
Exhibit 1003, Declaration of Mr. Brian T. Hart from U.S. Pat. No. 8,374,887. |
Exhibit 1004, Declaration of Wayne H. Grant from U.S. Pat. No. 8,374,887. |
Exhibit 1005, 22 TAC §§291.20, 291.36, and 291.71-291.74 date issued Mar. 5, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1006 U.S. Pat. No. 6,711,460 Reese issued Mar. 23, 2004 from U.S. Pat. No. 8,374,887. |
Exhibit 1009, Peterson et al., The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities; the journal of Pharmacy Technology, vol. 20, No. 1, Jan./Feb. 2004—pp. 1-39 from U.S. Pat. No. 8,374,887. |
Exhibit 1010, Declaration of Benjamin E. Weed from U.S. Pat. No. 8,374,887. |
Exhibit 1011, Complaint—Alexander v. Baxter, (W.D.Texas 2014) filed Mar. 13, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1012, Charles F. Seifert et al., “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education, 2004; 68 (3) Article 60—pp. 1-9 from U.S. Pat. No. 8,374,887. |
Exhibit 1013, Assignment Emily H. Alexander to Becton, Dickinson and Company; U.S. Appl. No. 13/747,231; Reel 034110/Frame 0789 from U.S. Pat. No. 8,374,887. |
Exhibit 1014, Exhibit A—Corrected Parties' Claims Construction Terms, Proposed Construction and cites Civil, 1:14cv-00222-LY—pp. 1-7 from U.S. Pat. No. 8,374,887. |
Exhibit 1015, Information about Telepharmacy presentation 42503 and Presentation Telepharmacy at Texas Tech; Jon Phillips—1-27 from U.S. Pat. No. 8,374,887. |
Exhibit 1017, Declaration of Dr. Roger W. Anderson in Support of Becton, Dickinson & Company's Response to Baxter's Motion for Summary Judgment of Invalidity Based Upon 35 U.S.C. § 101 filed Jan. 15, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1018, Plaintiff's Claim Construction Brief, 1:14-cv-222-LY filed Oct. 17, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1019, Plaintiff's Reply Claim Construction Brief, 1:14-cv-222-LY filed Nov. 7, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1020, The United States Pharmacopeia—the Official Compendia of Standards; 2004 from U.S. Pat. No. 8,374,887. |
Exhibit 1021, Curriculum Vitae of Brian T Hart from U.S. Pat. No. 8,374,887. |
Exhibit 1022, Curriculum Vitae of Wayne H Grant—Expert oversight—Expert Witness—Litigation Support from U.S. Pat. No. 8,374,887. |
Exhibit 1023, Charles D Peterson et al., “The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities,” J Pharm Technol, 2004; vol. 20—pp. 028-039 from U.S. Pat. No. 8,374,887. |
Exhibit 1025, Affidavit of Christopher Butler with attached Telemedicine Report Archive dated Mar. 4, 2015—6 pages from U.S. Pat. No. 8,374,887. |
Exhibit 1026, Affidavit of Christopher Butler with attached presentation Telepharmacy at Text Tech—Jon Phillips dated Mar. 4, 2015—31 pages from U.S. Pat. No. 8,374,887. |
Exhibit 1027, Order on Motion for Summary Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1028, Final Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1029 Charles Seifert from U.S. Pat. No. 8,374,887. |
Exhibit 1030 Deposition of Charles Seifert Dec. 4, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1031 Deposition of Diane B. Ginsburg, PhD. Dec. 16, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1032 Texas Administrative Code, Title 22, Chapter 291, Subchapter A, Section 291.23 as in effect on Feb. 1, 2004 from U.S. Pat. No. 8,374,887. |
Felkey, Bill G., “Integrating Technology at the Point of Care”, Insight, Jan. 2004—pp. 8-10. |
Formula for Patient Safety; ScriptPro; Aug. 17, 2003. |
Fred Puckett, “Medication-management component of a point-of-care information system,” Am. J. Health-Syst.Pharm., Jun. 15, 1995, pp. 1305-1309, vol. 52, American Society of Health-System Pharmacists, Inc. |
“GE ImageQuant TL 7.0 Image Analysis Software” User Manual , May 2007, http://nba.uth.tmc.edu/Assets/pdf/other/typhoon-supporting-files/IQTL-UserManual.pdf, Uppsala, Sweden. |
Gerald E. Meyer et al., “Use of bar codes in inpatient drug distribution,” Am. J. Hosp. Pharm., May 1991, pp. 953-966, vol. 48, American Society of Hospital Pharmacists, Inc. |
Ghent, Natale, “Pharmacists go digital to fight shortage”, Pharmacy Practice 20.11 (Nov. 2004): 47—2 pages. |
Gilad J. Kuperman, M.D. et al., “Innovations and research review: The impact of the Help computer system on the LDS Hospital paper medical record,” Topics in Health Record Management, 1991, pp. 76-85, vol. 12, Issue 2, Aspen Publishers, Inc. |
“Global Med Announces First Safetrace TX™ Sale,” Apr. 1, 1999, 2 pages. |
Global Med Technologies, Inc. Introduces PeopleMed™.com, inc., A Chronic Disease Management Application Service Provider (ASP) Subsidiary, Jan. 11, 2000, 2 pages, Global med Technologies, Inc., Denver, CO. |
Gretchen A. Barry et al., “Bar-code technology for documenting administration of large-volume intravenous solutions,” American Journal of Hospital Pharmacy, Feb. 1989, pp. 282-287, vol. 46, American Society of Hospital Pharmacists. |
H. Paul Hammann et al., “A World Wide Web Accessible Multi-Species ECG Database,” 1997, pp. 7-12, ISA. |
Halverson, Daniel R. IsoRx: TelePharmacy Software presentation—23 pages. |
Henry J. Lowe et al., “WebReport: A World Wide Web Based Clinical Multimedia Reporting System,” 1996, pp. 314-318, Amia, Inc. |
“Hospitals battle errors with bar codes,” Mar. 24, 2004, 3 pages, MSNBC. |
Howard L. Bleich et al., “Clinical Computing in a Teaching Hospital,” Use and Impact of Computers in Clinical Medicine, 1987, pp. 205-223 and selected pages, Springer-Verlag, New York, NY. |
http://isorx.com/ Jan. 29, 2004. |
http://www.scriptpro.com/products//sp-200/main.htm, Feb. 13, 2004, Product listing for SP 200® Robotic Prescription Dispensing System. |
http://www.scriptpro.com/products/space/space200.htm, Feb. 10, 2004, Product listing for SP Automation Center 200TM (Space 200TM) Prescription Dispensing Automation Center. |
Hughes, Shirley, “Bedside Terminals: Clinicom,” Clinical Computing, Jan./Feb. 1988, pp. 22-28, vol. 5, No. 1. |
IPR Decision Paper No. 8 Entered Aug. 13, 2015 from U.S. Pat. No. 8,374,887. |
IPR Final Written Decision Paper No. 29 Entered Jul. 11, 2016 from U.S. Pat. No. 8,374,887. |
James Kazmer et al., “The Creation of Virtual Electronic Medical Record,” 1996, 17 pages. |
Jennifer Langham; “Taking Automation to New Levels,” Insight, the QS/1 Magazine, Oct. 2002; pp. 2-5. |
John Frady; “What's New in RxCare Plus 17.2,” Insight, the QS/1 Magazine, Apr. 2002; pp. 2-3, 14. |
Jones, et al., “Use of a remote computerized system for study documentation in clinical trials” Drug Information Journal, Oct.-Dec. 1998, vol. 32, No. 4 oe pp. 1153-1163. |
Karen E. Bradshaw et al., “Physician decision-making—Evaluation of data used in a computerized ICU,” International Journal of Clinical Monitoring and Computing, 1984, pp. 81-91, vol. 1, Martinus Nijhoff Publishers, Netherlands. |
Kastango, Eric S. and Bradshaw, Brian D., “USP chapter 797: Establishing a practice standard for compounding sterile preparations in pharmacy” Am J Health-Syst Pharm., Sep. 15, 2004, vol. 61—pp. 1928-1938. |
Kenneth N. Barker et al., “Effect of an automated bedside dispensing machine on medication errors,” American Journal of Hospital Pharmacy, Jul. 1984, pp. 1352-1358, vol. 41, No. 7, American Society of Hospital Pharmacists. |
Keeys, Christopher A. et al., “Providing nighttime pharmaceutical services through telepharmacy” Am J Health-Syst Pharm, Apr. 15, 2002, vol. 59—pp. 716-721. |
Khan, Shamima et al., “Is There a Successful Business Case for Telepharmacy?” Telemedicine and e-Health, vol. 14, No. 3, Apr. 2008, pp. 235-245. |
Kimber, Michael B. et al., “Telepharmacy-Enabling Technology to Provide Quality Pharmacy Services in Rural and Remote Communities” Journal of Pharmacy Practice and Research, vol. 36, No. 2, 2006—128-133. |
Kodak DirectView PACS—Rural Hospital Joins the Big Leagues PACS/Enterprise Information management (EIM) Solution—www.kodak.com/go/medical—4 pages. |
Kosub, David, “Device allows pharmacy care in remote areas” Pharmacy Practice, vol. 20, No. 10, Oct. 2004—pp. 12-13. |
Koutnik, Eileen, Assistnat Editor, Pharmacy Times, “The Pharmacy of Tomorrow” Pharmacy Times, Aug. 1, 2003—3 pages. |
Larry B. Grandia, B.S.E. et al., “Building a computer-based Patient Record System in an Evolving Integrated Health System,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 19-55, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Lefkowitz, Sheldon et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System,” 1991, pp. 239-242, Hospital Pharmacy, vol. 26. |
LP, “ATM-STyle Drug Dispensers Taking Hold In Areas With Limited Pharmacist Services” Pharmacy Practice News, Jan. 2004, vol. 31, No. 1—4 pages. |
“The Longitudinal Clinical Record: A View of the Patient, taken from Proceedings of the 1994 Annual HIMSS Conference, Feb. 14, 1994, pp. 239-250, Healthcare Information and Management Systems Society, Chicago, Illinois, USA.” |
Lustig, Ahuva, “Medication error prevention by pharmacists—An Israeli solution” Pharmacy World & Science, 2000, vol. 22, No. 1—pp. 21-25. |
Medicaid Memo—Department of Medical Assistance Services (Converting NDCs from 10-digits to 11-digits) May 31, 2007. |
Medcin® Technical Overview, undated, 111 pages, Medicomp Systems. |
Michael H. Mackin, “Impact of Technology on Environmental Therapeutic Device Design,” Medical Instrumentation, Feb. 1987, pp. 33-35, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
Michelle M. Casey, M.S., Jill Klingner, R.N., M.S., and Ira Moscovice, Ph.D.; “Access to Rural Pharmacy Services In Minnesota, North Dakota, and South Dakota,” Working Paper Series, Jul. 2001, #36. |
Monane et al., “Improving Prescribing Patterson for the Elderly Through an Online Drug Utilization Review Intervention”, JAMA, Oct. 14, 1998, vol. 280, No. 14—pp. 1249-1252. |
Morris, Aisha M., Schneider, Philip J., Pedersen, Craig A. and Mirtallo, Jay M. “National survey of quality assurance activities for pharmacy-compounded sterile preparations” Am J Health-Syst Pharm, Dec. 15, 2003, vol. 60—pp. 2567-2576. |
Murray, Michael D. et al. “Effects of Computer-based Prescribing on Pharmacist Work Patterns” Journal of the American Medical Informatics Association, Nov./Dec. 1998, vol. 5, No. 6—pp. 546-553. |
Napoli, M. et al., “Picture archiving and communication in radiology”, Rays. Jan.-Mar. 2003—PubMed-NCBI http://www.ncbi.nlm.m=nih.gov/pubmed/14509181—Abstract. |
Nissen et al., Can telepharmacy provide pharmacy services in the bush, School of Pharmacy, University of Queensland, Brisbane, Australia, Journal of Telemedicine and Telecare 2003, vol. 9 (Suppl. 2): S2:39-41. |
North Dakota Century Code Statute Law—State Board of Pharmacy—219 pages. |
Parks, Liz, “Annual report of retail pharmacy: Using central-fill to maximize dispensing” Drug Store News, Aug. 20, 2001 vol. 24, No. 11—pp. 51, 75. |
Parsons, et al., “Digital Media—Can I Change a Graphic's File Size?”, New Perspectives on Computer Concepts—Course Technology, 2011, Cengage Learning, Boston, MA. |
Paul H. Perlstein et al., “Computer-Assisted Newborn Intensive Care,” Pediatrics, Apr. 1976, pp. 494-501, vol. 57, No. 4, American Academy of Pediatrics, Inc., Evanston, Illinois. |
Paul H. Perlstein et al., “Future Directions for Device Design and Infant Management,” Medical Instrumentation, Feb. 1987, pp. 36-41, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
PCA II Multi-Mode Cartridge Operator's Manual, Sep. 1995, approx. 40 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Pesce, James, “Bedside Terminals: Medtake,” Clinical Computing, Jan. /Feb. 1988, pp. 16-21, vol. 5, No. 1. |
Peter Lord et al., MiniMed Technologies Programmable Implantable Infusion System, Annals New York Academy of Science, pp. 66-71, describing clinical trials from Nov. 1986. |
Peterson et al., The North Dakota Telepharmacy Project Restoring and Retaining Pharmacy Services in Rural Communities—Presentation North Dakota State University, Fargo, North Dakota. |
Petition for Inter Partes Review Baxter International Inc. v. Becton, Dickinson and Company for U.S. Pat. No. 8,374,887, pp. 1-69. |
Pharmacy Automation Online Vendors Page; Internet Archive Wayback Machine; http://pharmacyautomation.com/vendors.html—3 pages. |
Pharmacy Data Management (PDM) Technical Manual/Security Guide Version 1.0, Sep. 1997—55 pages. |
Pharmacy education and practice out of sync? (Roundtable) Chain Drug Review, vol. 25, No. 6, Mar. 17, 2003, RX2 (6). |
Prem S. Chopra, Virgil A. Thomason, and Dell M. Stinett; “Voice-Activated Networked Workstation for a Physically Disabled Physician,” 10-7803-2050-6/94 1994 IEEE, pp. 478-479. |
Product literature, Baxter Healthcare Corporation, “Flo-Gard® 6201 Volumetric Infusion Pump,” 1992, 2 pages. |
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” 1988, 2 pages. |
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” undated, 2 pages. |
Remote Dispensing Regulations, NABPLAW Sep. 2003. |
Woodall, Sandra C., Remote Order Entry and Video Verification; Reducing After-Hours Medication Errors in a Rural Hospital; S. Woodall; Joint Commission on Accreditation of Healthcare Organizations; vol. 30; No. 8, Aug. 2004. |
Rich Muller; “NRx QS/1's Premium Pharmacy Software,” Insight, the QS/1 Magazine, Jul. 2003; pp. 2-3, 12-15. |
Rouse, et al., Academy of Managed Care Pharmacy et al., “White paper on pharmacy technicians 2002: Needed changes can no longer wait” Am J Health-Syst Pharm, Jan. 1, 2003, vol. 60—pp. 37-51. |
Rule Section 291.36—Class A Pharmacies Compounding Sterile Pharmaceuticals—1 page. |
Schrenker, Richard and Cooper, Todd, “Building the Foundation for Medical Device Plug-and-Play Interoperability”. |
Seifert et al.; “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education 2004; 68 (3) Article 60. Jul. 16, 2004. |
Standard Specification for Transferring Clinical Laboratory Data Messages Between Independent computer Systems, Annual Book of ASTM Standards, Mar. 25, 1988, pp. 1-16, E 1238-88, Global Engineering Documents, Philadelphia, PA. |
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Annual Book of ASTM Standards, Jun. Mar. 1994, pp. 132-210, E 1238-94, Philadelphia, PA. |
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Aug. 10, 1997, 79 pages, ASTM E 1238-97, West Conshohocken, PA, United States. |
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Annual Book of ASTM Standards, Jun. 1991, 15 pages, E 1394-91, Philadelphia, PA. |
Suzanne Carter, RN, Ed.D. et al., “The Computer-based Patient Record: The Jacobi Medical Center Experience,” Second Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1996, pp. 71-95, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
T. Allan Pryor et al., “help—A Total Hospital Information System,” Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, Nov. 2-5, 1980, pp. 3-7, vol. 1, Institute for Electrical and Electronics Engineers, New York, NY. |
T.E. Bozeman et al., “The Development and Implementation of a Computer-Based Patient Record in a Rural Integrated Health System,” Third Annual Nicholas E. David Award Proceedings of the CPR Recognition Symposium, 1997, pp. 101-130, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
“Telepharmacy project expands students' practice experience” Telemedicine Report, vol. 6, No. 1, Jan. 2004 oe 4 pages. |
The World's First Fully Integrated Workflow Manager for I.V. Rooms, IntelliFlowRx Brochure, For Health Technologies Inc,. United States, May 2008. |
Title 22. Examining Boards, 22 TAC Section 1.161; texinfo.library.unt.edu/Texasregister/html/2001/sep-14/PROPOSED/22.EXAMING BOARDS.html—Sep. 20, 2014, pp. 1-70. |
Ukens, Carol, “Pharmacist shortage boosts telepharmacy” Drug Topoics, Jun. 3, 2002; 146, 11—p. 53. |
Valeriy Nenov et al., “Remote Analysis of Physiological Data from Neurosurgical ICU Patients,” Journal of the American Medical Informatics Association, Sep./Oct. 1996, pp. 318-327, vol. 3, No. 5. |
“Victor J. Perini et al., Comparison of automated medication-management systems,: Am. J. Hosp. Pharm., Aug. 1, 1994, pp. 1883-1891, vol. 51, American Society of Hospital Pharmacists, Inc.”. |
Vincenzo Della Mae et al., “HTML generation and semantic markup for telepathology,” Computer Networks and ISDN Systems, 1996, pp. 1085-1094, vol. 28, Elsevier Science B.V. |
Website information for Cartharsis Medical Technology Products, Dec. 9, 2001, 15 pages. |
Website information for MedPoint™, Mar. 13, 2003, 20 pages, Bridge Medical, Solana Beach, CA. |
William R. Dito et al., “Bar codes and the clinical laboratory: adaptation perspectives,” Clinical Laboratory Management Review, Jan./Feb. 1992, pp. 72-85, Clinical Laboratory Management Association, Inc. |
Wills, Robert D., “Drug Images and Drug Imprints” Insight, Apr. 2001—p. 7. |
Yvonne Mari Abdoo, “Designing a Patient Care Medication and Recording System that Uses Bar Code Technology,” Computers in Nursing, May/Jun. 1992, pp. 116-120, vol. 10, No. 3. |
Jon Phillips, Telepharmacy at Texas Tech, PowerPoint, Jan. 26, 1997, https://web.archive.org/web/20040509162423/http:/www.ttuhsc.edu/telemedicine/Powerpoint/Telepharmacy%20presentation%2042503.ppt. |
A.H. McMorris et al. “Are Process Control Rooms Obsolete?”, Control Engineering, pp. 42-47, Jul. 1971. |
Standard Specification for Transferring Clinical Observations between Indepdendent Computer Systems, Annual Book of ASTM Standards, Nov. 14, 1991, pp. 1-64, ASTM E 1238-91,Philadelphia, PA. |
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Dec. 10, 1997; 15 pages, ASTM E 1394-97, West Conshohocken, PA, United States. |
Web site information, Information Data Management, Inc.'s PCMS: Plasma Center Management System, Dec. 14, 2001, 11 pages. |
Web site Information, Wyndgate Technologies' SafeTrace Tx™, undated, 15 pages. |
Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems, Mar. 11, 1991; 7 pages, ASTM E 1381-91, Philadelphia, PA, United States. |
Atherton, H.D., Dollberg, S., Donnelly, M.M., Perlstein, P. H. Roath, S.B., “Computerized Temperature Control of the Low-Birth-Weight Infant: A 20-Year Retrospective and Future Prospects,” Biomedical Instrumentation and Technology, Jul./Aug. 1994, pp. 302-309, vol. 28 No. 4. |
Friesdorf, W., Grob-Alltag, F., Konichezky, S., Schwilk, B., Fattroth, A., Fett, P., “Lessons learned while building an integrated ICU workstation,” International Journal of Clinical Monitoring and Computing, 1994, pp. 89-97, vol. 11. |
Gammon, K., Robinson, K., “Bedside Data System Aids Pharmacy,” Computers in Healthcare, Dec. 1988, pp. 35-37, vol. 9 No. 12. |
Graseby 3100 Syringe Pump, Graseby Medical Ltd., A Cambridge Electronic Industries Company, England, 2 pages. |
Kampmann, J., Lau, G., Kropp, ST., Schwarzer, E., Hernandez Sande, C., “Connection of electronic medical devices in ICU according to the standard ‘MIB’,” International Journal of Clinical Monitoring and Computing, 1991, pp. 163-166, vol. 8. |
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999 (32 pages). |
Carson, Ewart et al., “A Systems Methodology for the Development and Evaluation of a Telematic Home Haemodialysis Service,” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997, Chicago, Illinois, pp. 907-910. |
Communication pursuant to Article 94(3) EPC dated Jun. 12, 2019 in corresponding EP Application No. 18 000 180.2. |
Anonymous: “Sceye document scanner for the professional desktop”, 2011, pp. 1-2, XP055590334, Retrieved from the Internet: URL: https://www.tradescanners.com/pdf/sceye-brochure.pdf. |
Canadian Office Action/Notice of Requisition dated Dec. 27, 2018 mailed in corresponding Canadian Application No. 2,889,210. |
Number | Date | Country | |
---|---|---|---|
20190035498 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
61719235 | Oct 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15339390 | Oct 2016 | US |
Child | 16146437 | US | |
Parent | 14438544 | US | |
Child | 15339390 | US |